1,5-anhydroglucitol has been researched along with deoxyglucose in 333 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (8.71) | 18.7374 |
| 1990's | 85 (25.53) | 18.2507 |
| 2000's | 57 (17.12) | 29.6817 |
| 2010's | 137 (41.14) | 24.3611 |
| 2020's | 25 (7.51) | 2.80 |
| Authors | Studies |
|---|---|
| Pitkänen, E; Servo, C | 1 |
| Kitaoka, M; Sasaki, T; Taniguchi, H | 1 |
| Akanuma, H; Morita, M | 1 |
| Gomez, G; Izukura, M; Kogire, M; Mochizuki, T; Oshima, K; Sumi, S; Thompson, JC; Uchida, T; Yanaihara, N; Yoshinaga, K | 1 |
| Fukumura, Y; Ichimura, S; Jinnouchi, T; Kajiwara, K; Kobayashi, I; Murahashi, Y; Oshitani, S; Tajima, S; Tanaka, S; Ushijima, Y | 1 |
| Akanuma, H; Akaoka, I; Minoda, S; Miyashita, H; Moromizato, H; Shinohara, T; Tachibana, Y; Yamanouchi, T | 1 |
| Pitkänen, E; Pitkänen, OM | 2 |
| Kawagishi, T; Morii, H; Nishizawa, Y; Okuno, Y; Sekiya, K; Shoji, T | 1 |
| Emoto, M; Inoue, T; Morii, H; Nishizawa, Y; Tabata, T | 1 |
| Akaoka, I; Minoda, S; Miyashita, H; Moromizato, H; Shinohara, T; Yamanouchi, T | 1 |
| Baqué, S; Carabaza, A; Ciudad, CJ; Guinovart, JJ | 1 |
| Cleland, WW; Jones, JP; Weiss, PM | 1 |
| Akanuma, Y; Baba, S; Kanazawa, Y; Kawai, T; Kawazu, S; Kuzuya, T; Ohta, M; Toyota, T; Yamanouchi, T; Yoshioka, S | 1 |
| Hisatomi, A; Ishii, H; Nakashima, N; Nawata, H; Umeda, F; Yamauchi, T | 1 |
| Akaoka, I; Yamanouchi, T | 1 |
| Akanuma, H; Akanuma, Y; Akaoka, I; Miyashita, E; Yamanouchi, T | 1 |
| Pitkänen, E | 5 |
| Hamada, T; Ishimatsu, J; Matsunaga, T; Tetsuo, M; Yoshimatsu, K | 1 |
| Fuda, H; Harada, K; Hatano, M; Kawano, Y; Maruyama, S; Sugiura, M; Uno, K | 1 |
| Akanuma, Y; Akaoka, I; Yamanouchi, T | 1 |
| Kawai, A | 1 |
| Akanuma, H; Akanuma, Y; Akaoka, I; Minoda, S; Miyashita, H; Yabuuchi, M; Yamanouchi, T | 1 |
| Akanuma, H; Aoyagi, T; Kobayashi, T; Sakaguchi, T; Umezawa, H; Wada, T | 1 |
| Akanuma, H; Katoh, K; Masuda, M; Nakamura, T; Yabuuchi, M | 1 |
| White, TK; Wilson, JE | 1 |
| Akanuma, H; Akanuma, Y; Takaku, F; Yamanouchi, T | 1 |
| Akanuma, H; Akanuma, Y; Fukuzawa, N; Morita, M; Yamanouchi, T | 1 |
| Akanuma, H; Akanuma, Y; Suzuki, M | 1 |
| Akanuma, H; Akanuma, Y; Akaoka, I; Nakamura, T; Yamanouchi, T | 1 |
| Akanuma, H; Akanuma, Y; Hashimoto, Y; Kametani, S; Yamanouchi, T | 1 |
| Akanuma, H; Akanuma, Y; Akaoka, I; Asano, T; Konishi, C; Yamanouchi, T | 1 |
| Hamada, T; Morita, T; Nakayama, Y; Tetsuou, M | 1 |
| Akanuma, H; Naito, A; Nakamura, T; Takahashi, Y | 1 |
| Eisenthal, R; Game, S; Holman, G | 1 |
| Arase, K; Fujimoto, K; Fukushima, M; Sakata, T; Simpson, A; Terada, K | 1 |
| Lajunen, K; Miettinen, U; Pitkänen, E; Purokoski, S | 1 |
| Arase, K; Fukushima, M; Hinohara, Y; Oomura, Y; Sakata, T; Tsutsui, K | 1 |
| Cohen, P; Dix, D | 1 |
| BeMiller, JN; Grynkiewicz, G | 1 |
| Pitkänen, E; Pitkänen, O | 1 |
| Fujimori, A; Fujisawa, T; Funabashi, M; Saitoh, S; Takatani, O; Yoshioka, S | 1 |
| Akanuma, H; Akanuma, Y; Lee, Y; Ogawa, K | 1 |
| Arase, K; Fukushima, M; Kita, H; Nicolaidis, S; Ohki, K; Oomura, Y; Sakata, T; Tsutsui, K | 1 |
| Elvebak, LE; Gray, GR | 1 |
| Arai, K; Kamada, T; Kawamori, R; Kishimoto, M; Kubota, M; Morishima, T; Yamasaki, Y | 1 |
| Chusney, GD; Philippa, M; Pickup, JC | 1 |
| Akaoka, I; Minoda, S; Miyashita, H; Ogata, N; Sekino, N; Tachibana, Y; Yamanouchi, T | 1 |
| Fujita, S; Katayama, Y; Matsuyama, T | 1 |
| Fujimoto, H; Fujimoto, K; Funasako, M; Higashimoto, Y; Nakai, S; Ohata, M; Sakagami, Y; Suruda, T; Taniji, M; Uetani, K | 1 |
| Chusney, GD; Pickup, JC | 1 |
| Kondo, T; Miyakawa, M; Nakamura, K; Sakurai, Y; Shimada, N; Teruya, K | 1 |
| Akanuma, Y; Yamanouchi, T | 1 |
| Furuya, E; Mino, M; Namba, N; Tokuda, M; Watanabe, F | 1 |
| Ishida, T; Kajikawa, T; Kawanishi, K; Tada, S | 1 |
| Frattali, AL; Wolf, BA | 1 |
| Fukahori, K; Kato, Y; Koyashiki, Y; Tajima, S; Tanabe, T; Umegae, Y; Yabuuchi, M | 1 |
| Fukumura, Y; Hara, F; Kobayashi, I; Oshitani, S; Tajima, S; Ushijima, Y; Yabuuchi, M; Yamamoto, S | 1 |
| Farrant, RK; Frith, RG; James, SK; Phillipou, G; Phillips, PJ | 1 |
| Furusawa, M; Goto, Y; Kiba, N | 1 |
| Akanuma, H; Akaoka, I; Miyashita, H; Sekino, N; Tachibana, Y; Yamanouchi, T | 1 |
| Akanuma, H; Akanuma, Y; Mizuno, H; Suzuki, M | 1 |
| Akanuma, H; Mizuno, H; Shiga, Y | 1 |
| Haruna, M; Okuda, J; Taguchi, T | 1 |
| Dewald, L; Kajita, M; Miyazaki, T; Niwa, T; Sone, J | 1 |
| Fukumura, Y; Kobayashi, I; Oshitani, S; Ushijima, Y; Yoshii, C | 1 |
| Nagai, M; Sakata, K; Shirahama, S; Sueta, H; Tanaka, T; Yanagawa, H | 1 |
| Akanuma, H; Mizuno, H; Morita, M | 1 |
| Akaoka, L; Funato, H; Kawasaki, T; Miyashita, H; Ogata, N; Sekino, N; Tagaya, T; Yamanouchi, T | 1 |
| Yamanouchi, T | 5 |
| Akaoka, I; Miyashita, H; Ogata, N; Shinohara, T; Tachibana, Y; Yamanouchi, T | 1 |
| Akanuma, H; Kametani, S; Suzuki, M; Uchida, K | 1 |
| Kobayashi, I; Tsukui, S | 1 |
| Fukatsu, T; Kato, C; Morishita, Y | 1 |
| Kakuchi, T; Kikuchi, A; Murabayashi, S; Satoh, T; Umeda, S; Yokota, K; Yuhta, T | 1 |
| Hishida, A; Kato, A; Yamada, H; Yoneyama, T | 1 |
| Fukumura, Y; Kobayashi, I; Tsukui, S | 1 |
| Akanuma, H; Kametani, S; Mizuno, H; Shiga, Y | 2 |
| Shiba, T | 1 |
| Mathew, TH; Ninan, VT; Phillipov, G | 1 |
| Inui, K; Ohtomo, T; Saito, H | 1 |
| Fukasawa, H; Hotta, N; Kakuta, H; Koh, N; Naruse, K; Sakakibara, F; Takeuchi, N; Yamada, K; Yamada, T | 1 |
| Horiuchi, S; Sode, K; Tanaka, M; Tsugawa, W; Wake, H | 1 |
| Akanuma, H; Kametani, S; Shiga, Y | 1 |
| Kawai, K; Kawakami, Y; Matsushima, T; Odawara, M; Okuda, Y; Sone, H; Yamaoka, T; Yamashita, K | 1 |
| Ishii, C; Ito, Y; Kato, N; Kawazu, S; Komeda, K; Nagai, R; Ohno, T; Tomono, S; Utsugi, T | 1 |
| Azukari, K; Kondo, M; Yoshida, T; Yoshioka, K | 1 |
| Furusawa, M; Kiba, N; Saegusa, K | 1 |
| Ichimura, S; Machida, R; Okawa, E; Suzuki, T; Tajima, S; Tanabe, T; Yabuuchi, M | 1 |
| Stickle, D; Turk, J | 1 |
| Hashimoto, T; Nishibu, M; Oba, N; Senda, Y; Shibayama, M | 1 |
| Akanuma, H; Kametani, S | 1 |
| Arisaka, T; Honda, N; Kawamori, R; Kinoshita, J; Kurahashi, Y; Mochizuki, K; Nakamura, M; Tohjima, T; Watanabe, K; Yamamoto, S; Yoshimoto, T | 1 |
| Aso, Y; Inukai, T; Takemura, Y | 1 |
| Kogure, A; Kondo, M; Sakane, N; Yoshida, T | 1 |
| Funato, H; Inoue, T; Kawasaki, T; Koshibu, E; Miyashita, H; Ogata, N; Sekino, N; Yamanouchi, T; Yoshimura, T | 1 |
| Akaoka, I; Funato, H; Inoue, T; Kawasaki, T; Koshibu, E; Miyashita, H; Ogata, N; Yamanouchi, T; Yoshimura, T | 1 |
| Ohta, M; Yamagishi, S | 1 |
| Hasegawa, T; Hasegawa, Y; Kurimoto, F; Takada, M; Tsuchiya, Y | 1 |
| Akanuma, H; Kadokura, T; Kametani, S; Shiga, Y | 1 |
| Babaya, N; Fujisawa, T; Ikegami, H; Kawabata, Y; Kawaguchi, Y; Nishino, M; Nojima, K; Noso, S; Ogihara, T; Ono, M; Shintani, M; Tsutsui, T; Ueda, H; Yamada, K | 1 |
| Addison, GM; Keevilt, BG; Kilpatrick, ES; Newland, P; Richmond, KL | 1 |
| Kondo, T; Miyakawa, M; Shimada, N; Shirasaya, K; Takahashi, E; Yoshida, K | 1 |
| Akanuma, Y | 1 |
| Hayakawa, T; Inada, M; Miyake, Y; Nishikawa, M; Omoto, S; Shimizu, H; Shouzu, A; Yonemoto, T | 1 |
| Inoue, T; Kashiwabara, A; Kawasaki, T; Muraoka, H; Ogata, E; Ogata, N; Yamanouchi, T; Yoshimura, T | 1 |
| Hamafuji, T; Sode, K; Sugiura, H; Tsugawa, W; Watazu, Y | 1 |
| Aiso, Y; Fujimori, S; Inoue, T; Kashiwabara, A; Kawasaki, T; Tanabe, T; Yamanouchi, T; Yoshimura, T | 1 |
| Hashima, K; Kishida, K; Konishi, Y | 1 |
| Arumanayagam, M; Lau, TK; Rogers, MS; Tam, WH | 1 |
| Ichiyanagi, K; Inoue, T; Kashiwabara, A; Kawasaki, T; Ogata, E; Ogata, N; Sekino, N; Yamanouchi, T; Yoshimura, T | 1 |
| Akanuma, Y; Kawakami, M; Ohashi, Y; Saito, Y; Tanaka, A; Yamada, N | 1 |
| Fang, J; Shen, Z; Shi, H; Yang, X; Zhu, X | 1 |
| Dworacka, M; Kuczynski, S; Szczawinska, K; Szymanska, M; Wierusz-Wysocka, B; Winiarska, H | 1 |
| Izumi, K; Noda, M | 1 |
| Fujisawa, T; Ikegami, H; Ogihara, T | 1 |
| Hamafuji, T; Sode, K; Tsugawa, W | 1 |
| Inoue, T; Kashiwabara, A; Kawasaki, T; Ogata, N; Sawashige, K; Sekino, N; Yamanouchi, T | 1 |
| Katsuragi, T; Tani, Y; Uchida, E; Yoshida, N | 1 |
| Buse, JB; Edelman, SV; Freeman, JL; Jovanovic, L; McGill, JB | 1 |
| KESTON, AS | 1 |
| Ichiyanagi, K; Inoue, T; Ogata, N; Sakai, T; Yamanouchi, T | 1 |
| Appell, M; Momany, FA; Strati, G; Willett, JL | 1 |
| Araki, A; Sasamoto, K; Shirabe, S; Yamanouchi, T; Yanagawa, T | 1 |
| Kimura, M; Shibasaki, T; Shiota, T; Suzuki, M; Tateishi, N; Yamauchi, H; Yoshie, F | 1 |
| Akanuma, H; Ichiyanagi, K; Kawasaki, T; Ogata, N; Sakai, T; Watanabe, H; Yamanouchi, T | 1 |
| Ammirati, EB; Cole, TG; Gautille, T; Houghton, S; McGill, JB; Nowatzke, W; Sarno, MJ | 1 |
| Kawamori, R; Miwa, S; Ohmura, C; Tanaka, Y; Watada, H | 1 |
| Birch, NC; Cole, TG; Eden, T; Nowatzke, W; Sarno, MJ; Stickle, DF | 1 |
| Fujikura, H; Hiratochi, M; Isaji, M; Isogai, T; Itoh, F; Maruyama, H; Sugiyama, T; Takemura, Y; Tazawa, S; Tomae, M; Wakamatsu, A; Yamato, T | 1 |
| Ito, C | 1 |
| Ito, C; Maeda, R | 1 |
| Dworacka, M; Winiarska, H | 1 |
| Del Prato, S; Hanefeld, M; Karrei, K; Koehler, C; Temelkova-Kurktschiev, T | 1 |
| Abramczyk, M; Borowska, M; Dworacka, M; Kuczynski, S; Szczawinska, K; Winiarska, H | 1 |
| Bobkiewicz-Kozłowska, T; Borowska, M; Brazert, J; Dworacka, M; Pietryga, M; Szczawinska, K; Wender-Ozegowska, E; Winiarska, H; Zawiejska, A | 1 |
| Gotoh, M; Hirooka, Y; Iguchi, A; Li, C; Yatoh, M | 1 |
| Goldie, MP | 1 |
| Buse, JB; Button, EA; Dungan, KM; Kato, S; Kelly, MM; Largay, J; Wittlin, S | 1 |
| Okahata, S; Terauchi, Y; Tobe, K | 1 |
| Asano, T; Hiramatsu, S; Ogo, A; Watanabe, A; Yoshizumi, H | 1 |
| Egawa, S; Gu, Y; Inoue, K; Matsuno, S; Qi, M; Sakata, N; Sumi, S; Sunamura, M; Unno, M; Yamamoto, C | 1 |
| Abramczyk, M; Bobkiewicz-Kozlowska, T; Borowska, M; Dworacka, M; Dworacki, G; Winiarska, H | 1 |
| Heptulla, RA; Mason, KJ; Nguyen, TM; Rodriguez, LM | 1 |
| Dungan, KM | 2 |
| Fei, X; Jing, F; Jun, L; Wang, Y; Yong, Z; Zhang, J; Zhu, M | 1 |
| Bobkiewicz-Kozłowska, T; Dworacka, M; Wegner, M; Winiarska, H | 1 |
| Allemann, S; Christ, E; Diem, P; Keller, U; Riesen, W; Schmidlin, K; Stahl, M; Stettler, C; Zwahlen, M | 1 |
| Button, EA; Gorczynska-Kosiorz, S; Klupa, T; Malecki, MT; Sieradzki, J; Skupien, J; Wanic, K | 1 |
| Aoki, K; Nakajima, S; Nezu, U; Shinoda, K; Terauchi, Y | 1 |
| Dutta, S; Kwagh, J; Langish, RA; Onorato, JM; Sanders, M; Shipkova, PA; Wang, J | 1 |
| Nerby, CL; Stickle, DF | 1 |
| Heng, X; Li, S; Sheng, H; Wang, Y; Yu, C | 1 |
| Bilo, HJ; Diamant, M; Schindhelm, RK; Slingerland, RJ | 1 |
| Choi, ES; Kim, JH; Kim, SW; Lee, WY; Oh, KW; Park, CY; Park, HS; Park, SW; Rhee, EJ; Won, JC | 1 |
| Buse, JB; Dungan, KM; Fahrbach, JL; Herman, WH; Jiang, H; Martin, S; Wolffenbuttel, BH | 1 |
| Kashiwagi, A; Nishio, Y | 1 |
| Kublaoui, BM; Oden, JD; Shah, S; White, PC | 1 |
| Kasayama, S; Koga, M; Moriwaki, Y; Mukai, M; Murai, J; Saito, H; Yamamoto, T | 1 |
| Christensen, BL; Williams, M | 1 |
| Ishii, S; Katabami, T; Kato, H; Kawata, T; Koganei, R; Kondo, A; Matsui, T; Murakami, K; Ohta, A; Sada, Y; Suwa, T; Tanaka, Y | 1 |
| Barrow, BA; Dudley, C; Farmer, AJ; Gloyn, AL; Grew, JP; Klyne, R; McCarthy, MI; Owen, KR; Pal, A; Selwood, MP | 1 |
| Smith, J | 1 |
| True, MW | 1 |
| Kasayama, S; Koga, M; Mukai, M; Murai, J; Saito, H | 2 |
| Ban, N; Endo, K; Kawana, H; Miyashita, Y; Murano, T; Nagayama, D; Nagumo, A; Ohira, M; Oyama, T; Saiki, A; Shirai, K; Watanabe, H; Yamaguchi, T | 1 |
| Hanafusa, T; Imagawa, A; Kasayama, S; Koga, M; Mukai, M; Murai, J; Saito, H | 1 |
| Bando, Y; Kanehara, H; Kasayama, S; Koga, M; Mukai, M; Murai, J; Saito, H; Tanaka, N; Toya, D | 1 |
| Goto, A; Goto, M; Kanazawa, Y; Noda, M; Shimbo, T; Terauchi, Y; Yamamoto-Honda, R | 1 |
| Rynders, GP; Selvin, E; Steffes, MW | 1 |
| Ballantyne, CM; Brancati, FL; Coresh, J; Hoogeveen, RC; Selvin, E; Steffes, MW | 1 |
| Higashiyama, A; Kokubo, Y; Miyamoto, Y; Okamura, T; Ono, Y; Watanabe, M | 1 |
| Keers, JC; Kerstens, MN; Kreugel, G; Wolffenbuttel, BH | 1 |
| Beck, R; Kollman, C; Mauras, N; Ruedy, K; Steffes, M; Wilson, DM; Xing, D | 1 |
| Arai, T; Hayakawa, N; Ishioka, K; Miki, Y; Mori, A; Niki, T; Oda, H; Saeki, K; Sako, T; Sato, T; Tazaki, H | 1 |
| Honma, A; Koyama, T; Miyamae, Y; Ogawa, A; Shigemori, H; Yazawa, K | 1 |
| Cho, SW; Hwang-Bo, Y; Jang, HC; Jung, HS; Kim, MJ; Kim, SY; Park, KS | 1 |
| Foo, JP; Mantzoros, CS | 1 |
| Hamaguchi, T; Katsuno, T; Konishi, K; Kusunoki, Y; Miuchi, M; Miyagawa, J; Murai, K; Nagai, E; Namba, M; Ochi, F; Tokuda, M | 1 |
| Davis, KE; Januszewski, AS; Jenkins, AJ; Karschimkus, C; O'Neal, D; Ward, G | 1 |
| Laffel, LM; Mehta, SN; Schwartz, N; Svoren, BM; Wood, JR | 1 |
| Kishimoto, M; Noda, M | 1 |
| Kim, WJ; Lee, KB; Lee, WY; Oh, KW; Park, CY; Park, SE; Park, SW; Rhee, EJ | 1 |
| Lei, CH; Sun, ZL; Wang, Y; Wang, YP; Zhang, YL | 1 |
| Hamano, K; Ishibashi, S; Kiyono, K; Kusaka, I; Nagasaka, S; Ogata, H; Struzik, ZR; Suzuki, H; Tokuyama, K; Tsuchita, T; Yamada, N; Yamamoto, Y | 1 |
| Ahn, HY; Kim, SW; Kim, WJ; Kim, YJ; Lee, WY; Oh, KW; Park, CY; Park, HS; Park, SE; Park, SW; Rhee, EJ; Song, SJ | 1 |
| Dou, JT; Lu, JM; Lü, ZH; Ma, FL; Mu, YM; Sun, J; Wang, XL; Yang, GQ; Zheng, H | 1 |
| Arakaki, RF; Buse, JB; Dungan, KM; Fahrbach, JL; Herman, WH; Jacobson, JG; Jiang, HH | 1 |
| Nakano, H; Oba, K; Ohara, M; Okazaki, M; Ouchi, M; Sekimizu, K; Suzuki, T; Tsunoda, M; Watanabe, K; Yamashita, H | 1 |
| Cao, X; Huang, Z; Li, Y; Liu, J; Liu, L; Wan, X | 1 |
| Hess, C; Madea, B; Musshoff, F; Quester, W; Stratmann, B; Tschoepe, D | 1 |
| Ando, K; Irako, T; Nishimura, R; Sakamoto, M; Tsujino, D; Utsunomiya, K | 1 |
| Juraschek, SP; Miller, ER; Selvin, E; Steffes, MW | 1 |
| Juraschek, SP; Selvin, E; Steffes, MW | 1 |
| Adachi, I; Ishikawa, F; Kato, A; Kunimatsu, T; Takeshita, K; Yamashita, Y | 1 |
| Cyganek, K; Malecki, MT; Matejko, B; Nowak, N; Skupien, J | 1 |
| Hashimoto, M; Ishii, K; Oba, K; Ohara, M; Okazaki, M; Ouchi, M; Suzuki, K; Suzuki, T; Watanabe, K; Yamashita, H | 1 |
| Chin, SO; Choi, MC; Chon, S; Fraterrigo, G; Kim, YS; Kwon, MK; Lee, YJ; Oh, S; Pozzilli, P; Rhee, SY; Woo, JT | 1 |
| Aoyama, J; Igari, Y; Ishii, K; Matsumura, N; Motoyama, M; Nakano, H; Oba, K; Ouchi, M; Sekimizu, K; Suzuki, T; Watanabe, K; Yano, H | 1 |
| Alejandro, R; Bozkurt, NC; Corrales, A; García, MI; Herrada, E; Lauriola, V; Messinger, S; Peixoto, EM; Ricordi, C | 1 |
| Albanes, D; Evans, AM; Karoly, ED; Mondul, AM; Moore, SC; Sampson, JN; Virtamo, J; Weinstein, SJ | 1 |
| Araki, E; Furukawa, N; Goto, R; Ichimori, S; Iwashita, S; Kawashima, J; Kondo, T; Maeda, T; Matsumura, T; Matsuo, T; Matsuo, Y; Motoshima, H; Nishida, K; Sekigami, T; Shimoda, S | 1 |
| Kawata, T; Matsubara, F; Nagai, Y; Nakamura, Y; Ohshige, T; Ohta, A; Sakai, K; Tanaka, Y; Tenjin, A; Terashima, Y; Tsukiyama, S | 1 |
| Chayama, K; Hashiba, M; Hirose, A; Hyogo, H; Ikeda, Y; Ishikawa, Y; Masuda, K; Munekage, K; Nagata, Y; Noguchi, S; Nozaki-Fujimura, Y; Ochi, T; Okamoto, N; Ono, M; Saibara, T; Suganuma, N; Yoshioka, R | 1 |
| Aoyama, J; Futami-Suda, S; Igari, Y; Ishii, K; Nakano, H; Oba, K; Ohara, M; Onishi, T; Ouchi, M; Suzuki, T; Tsunoda-Kubota, M; Yamashita, H | 1 |
| Balis, DA; Meininger, G; Tong, C | 1 |
| Abdul Kader, S; Al Muftah, WA; Al-Homsi, H; Al-Mahmoud, KA; Al-Obaidli, A; Chidiac, OM; Karoly, ED; Kocher, T; McKeon, C; Mook-Kanamori, DO; Mook-Kanamori, MJ; Rowe, J; Sekkal Gherbi, W; Selim, MM; Suhre, K; Takiddin, AH; Yousri, NA; Zirie, MA | 1 |
| Borowska, M; Dworacka, M; Dworacki, G; Iskakova, S; Krzyżagórska, E; Wesołowska, A | 1 |
| Dworacka, M; Dworacki, G; Iskakova, S; Wesołowska, A; Winiarska, H; Wysocka, E | 1 |
| Boritza, KC; da Silva Couto Alves, A; de Moraes Rego, FG; de Souza, EM; dos Santos-Weiss, IC; Pedrosa, FO; Picheth, G; Réa, RR | 1 |
| Hara, H; Hiroi, Y; Ikeda, N | 2 |
| Ako, J; Arao, K; Fujiwara, T; Funayama, H; Kakei, M; Katayama, T; Mitsuhashi, T; Momomura, S; Nakamura, T; Sakakura, K; Sugawara, Y; Tsukui, T; Wada, H; Yamada, H; Yoshida, M | 1 |
| Sato, A | 1 |
| Mori, H; Okada, Y; Tanaka, Y; Torimoto, K | 1 |
| Koga, M | 1 |
| Alexander, D; Boerwinkle, E; Coresh, J; Nettleton, JA; Yu, B; Zheng, Y | 1 |
| Aoki, C; Aso, Y; Kato, K; Niitani, M; Suzuki, K; Tanaka, S; Tomotsune, T | 1 |
| Coresh, J; Grams, M; Klein, R; Rawlings, AM; Selvin, E; Steffes, M | 1 |
| Lawler, PR; Mora, S | 1 |
| Parrinello, CM; Selvin, E | 1 |
| Hao, K; Ling, F; Liu, GL; Wang, GX; Yu, XB; Zhu, B | 1 |
| Chan, CL; Kelsey, M; Nadeau, KJ; Newnes, L; Pyle, L; Zeitler, PS | 1 |
| Araki, T; Inagaki, K; Kobayashi, F; Nakatsuka, T; Sanada, H; Tamura, T; Watanabe-Ishimaru, E | 1 |
| Bao, Y; Deng, Z; Hao, Y; Hu, X; Jia, W; Luo, Y; Ma, X; Zhou, J | 1 |
| Brown, Z; Gooley, TA; Hirsch, IB; Wright, LA | 1 |
| Nakashima, K; Nakashita, S; Nakayama, T; Takahashi, Y; Uemura, Y; Wada-Isoe, K; Yamamoto, M; Yamawaki, M | 1 |
| Bao, Y; Hao, Y; Hu, X; Jia, W; Lu, Z; Luo, Y; Ma, X; Zhou, J | 1 |
| Brown, Z; Coley, RY; Delaney, SS | 1 |
| Akashi, N; Ako, J; Arao, K; Fujiwara, T; Funayama, H; Kakei, M; Katayama, T; Mitsuhashi, T; Momomura, S; Nakamura, T; Sakakura, K; Sugawara, Y; Tsukui, T; Umemoto, T; Wada, H; Yamada, H; Yoshida, M | 1 |
| De Mieri, M; Guldbrandsen, N; Hamburger, M; Kostidis, S; Mikros, E; Schäfer, H; Skaltsounis, AL; Spraul, M | 1 |
| Higashiyama, A; Hirata, T; Imano, H; Kadota, A; Kubota, Y; Miyamatsu, N; Miyamoto, Y; Nishida, Y; Nishikawa, T; Nishimura, K; Okamura, T; Sugiyama, D | 1 |
| Fukuhara, M; Hata, J; Hirakawa, Y; Hotta, T; Ikeda, F; Kang, D; Kitazono, T; Kiyohara, Y; Koga, M; Mukai, N; Nakamura, U; Ninomiya, T | 1 |
| Burger, D; Faustman, DL; Hsu, E; Kuhtreiber, WM; Reinhold, P; Washer, SL; Zhao, M; Zheng, H | 1 |
| Ako, J; Fujiyoshi, K; Hashikata, T; Hashimoto, T; Kakizaki, R; Kameda, R; Kitasato, L; Maekawa, E; Namba, S; Nemoto, T; Shimohama, T; Tojo, T; Yamaoka-Tojo, M | 1 |
| Amaya, N; Arakawa, K; Fukuoka, Y; Ikeda, H; Ishida, K; Kaseno, K; Lee, JD; Morishita, T; Sato, T; Shiomi, Y; Tada, H; Tama, N; Uzui, H | 1 |
| Coresh, J; Lutsey, P; Maruthur, N; Pankow, JS; Rawlings, A; Selvin, E; Steffes, M | 1 |
| Kitao, T; Miyaishi, S; Takata, T; Yamasaki, Y | 1 |
| Agarwal, R; Babar, S; Blagden, S; Carme, S; Chen, M; Curry, E; Dina, R; El-Bahrawy, MA; Gabra, H; Gungor, H; Krachey, E; Madison, S; Morris, SR; Pickford, E; Rama, N; Saleem, A; Salinas, C; Santiago-Walker, A; Smith, DA; Stronach, EA | 1 |
| Coresh, J; Couper, D; Eckfeldt, JH; Lutsey, PL; Parrinello, CM; Selvin, E; Steffes, MW | 1 |
| Fortuna, D; McCloskey, LJ; Stickle, DF | 1 |
| Hasslacher, C; Kulozik, F | 1 |
| Bergenstal, RM; Coresh, J; Grams, ME; Maruthur, NM; Parrinello, CM; Selvin, E; Sharrett, AR | 1 |
| Kishihara, E; Koga, M; Matsubara, M; Mori, H; Moriya, T; Okada, Y | 1 |
| Abou-Samra, AB; Halama, A; Kader, SA; Kulinski, M; Mohammad, RM; Satheesh, NJ; Suhre, K | 1 |
| Lipsky, LM; Liu, A; Nansel, TR | 1 |
| Jeon, WS; Lee, WY; Oh, KW; Park, CY; Park, SE; Park, SW; Rhee, EJ | 1 |
| Davies, KP; Deng, GG; Wang, Y | 1 |
| Amaya, N; Fukuoka, Y; Ikeda, H; Ishida, K; Kaseno, K; Lee, JD; Morishita, T; Tada, H; Uzui, H | 1 |
| Chen, Y; Liang, M; McEvoy, JW; Selvin, E; Sharrett, AR | 1 |
| Hara, H; Hiroi, Y; Ikeda, N; Nakamura, M | 1 |
| Inada, S; Koga, M | 1 |
| Aikawa, T; Al Shahi, H; Daida, H; Hiki, M; Isoda, K; Kadoguchi, T; Miyauchi, K; Miyazaki, T; Ogita, M; Okazaki, S; Ouchi, S; Sai, E; Shimada, K; Shiozawa, T; Takahashi, S; Tamura, H; Tsuboi, S; Yoshihara, T | 1 |
| Lv, LY; Shi, DB; Zhou, Q | 1 |
| Baumgartner, A; Chan, CL; Kelsey, MM; Nadeau, KJ; Newnes, L; Pyle, L; Zeitler, PS | 1 |
| He, J; Lei, C; Sun, Z; Wang, Y; Yuan, Y; Zhang, Y; Zhou, Y | 1 |
| Baig, MH; Bhure, SK; Chaturvedi, N; Gupta, GK; Jan, AT; Pillai, H; Yadav, BS | 1 |
| Bao, Y; He, X; Jia, W; Ma, X; Su, H; Wang, Y; Yin, J; Zhou, J | 1 |
| Guo, M; Liu, Z; Ma, C; Sheng, J | 1 |
| Chen, H; Hu, M; Ni, S; Shen, N; Sun, L; Wang, J; Yang, X; Zhang, T; Zheng, K | 1 |
| Chen, Y; Coresh, J; Grams, ME; Gross, AL; Rebholz, CM; Sang, Y; Selvin, E | 1 |
| Appel, LJ; Christenson, RH; Juraschek, SP; Miller, ER; Sacks, FM; Selvin, E | 1 |
| Boerwinkle, E; Friedrich, N; Köttgen, A; Li, M; Loomis, SJ; Maruthur, NM; Mei, H; Morrison, AC; Nauck, M; North, KE; Pankow, JS; Pietzner, M; Selvin, E; Teumer, A | 1 |
| Glodzik, W; Hohendorff, J; Kapusta, M; Kiec-Wilk, B; Klupa, T; Ludwig-Galezowska, A; Malecki, MT; Mrozinska, S; Parpan, T; Platek, T; Skupien, J; Szopa, M; Zapala, B | 1 |
| Hata, J; Hirakawa, Y; Kishimoto, H; Kitazono, T; Kiyohara, Y; Koga, M; Mukai, N; Nakamura, U; Ninomiya, T; Ohara, T; Yoshida, D | 1 |
| Nakamura, S; Oku, T; Shimura, F; Tanabe, K; Yoshinaga, K | 1 |
| Butkovich, S; Nathan, DM; Petrasek, D; Young, GJ; Zekavat, SM | 1 |
| Kadowaki, T; Muto, S; Ouchi, Y; Seino, Y; Shimazaki, R | 1 |
| Bao, Y; He, X; Jia, W; Ma, X; Peng, J; Shen, Y; Su, H; Wang, Y; Ying, L; Zhou, J | 1 |
| Coresh, J; Grams, ME; Inker, LA; Köttgen, A; Levey, AS; Perrone, RD; Rebholz, CM; Sarnak, MJ; Shafi, T; Tin, A | 1 |
| Bao, Y; He, X; Hu, X; Jia, W; Ma, X; Peng, J; Su, H; Wang, Y; Ying, L; Zhou, J | 1 |
| Fujikawa, Y; Kanaya, Y; Kuriyama, M; Nishigaki, M; Shiga, Y; Shimoe, Y; Takamatsu, K; Takemaru, M; Takeshima, S | 1 |
| Aikawa, T; Daida, H; Hiki, M; Iwata, H; Kadoguchi, T; Kasai, T; Kato, T; Miyauchi, K; Miyazaki, T; Murata, A; Ouchi, S; Sai, E; Shimada, K; Shimizu, M; Suda, S; Sugita, Y; Takahashi, S | 1 |
| Bai, Y; Song, Y; Wang, Y; Yang, R | 1 |
| Bao, Y; He, X; Jia, W; Ma, X; Peng, J; Wang, Y; Yin, J; Ying, L; Zhou, J | 1 |
| Achamallah, N; Breathnach, F; Corcoran, SM; Dicker, P; Loughlin, JO; Malone, FD; Stafford, P | 1 |
| He, X; Sacks, DB; Saenger, AK; Selvin, E; Warren, B | 1 |
| Chen, J; Huang, Y; Li, G; Liang, J; Wang, Y; Wang, Z; Xue, W; Zhao, L; Zhou, Z | 1 |
| Azuma, T; Goto, A; Hidaka, A; Hirata, Y; Inoue, M; Iwasaki, M; Kobayashi, T; Nakagawa, T; Nishiumi, S; Sawada, N; Shimazu, T; Tsugane, S; Yamaji, T; Yamanaka, K; Yoshida, M | 1 |
| Mendes, N; Serrano, F; Tavares Ribeiro, R | 1 |
| Ballantyne, CM; Ballew, SH; Coresh, J; Ding, N; Folsom, AR; Heiss, G; Hirsch, AT; Hoogeveen, RC; Jaar, B; Kwak, L; Matsushita, K; Salameh, M; Selvin, E; Sharrett, AR | 1 |
| Hess, C; Kueting, T; Madea, B; Musshoff, F; Sydow, K | 1 |
| Anghebem-Oliveira, MI; Boritza, KC; Hauser, AB; Henneberg, R; Picheth, G; Rego, FGM; Welter, M | 1 |
| Ballantyne, CM; Grams, M; Hoogeveen, RC; Köttgen, A; Lee, AK; Pankow, JS; Selvin, E; Warren, B | 1 |
| Anjana, RM; Gokulakrishnan, K; Jayashri, R; Mohan, V; Pradeepa, R; Pramodkumar, TA; Saravanan, P; Uma, R; Velmurugan, K; Venkatesan, U | 1 |
| Glodzik, W; Hohendorff, J; Kapusta, M; Klupa, T; Malecki, MT; Matejko, B; Sani, CM; Skupien, J; Szopa, M; Ucieklak, D; Zapala, B | 1 |
| Padilha, K; Pereira, AC; Rhee, EP; Tavares, G; Thadhani, RI; Titan, SMO; Venturini, G; Zatz, R | 1 |
| Alshahrani, I; Amanullah, M; Dawasaz, AA; Syed, S; Togoo, RA; Yassin, SM | 1 |
| Boerwinkle, E; Coresh, J; Duggal, P; Gibbs, R; Köttgen, A; Li, M; Loomis, SJ; Muzny, D; Pankow, J; Selvin, E; Tin, A | 1 |
| Chalmers, J; Cooper, ME; Hamet, P; Harrap, S; Juraschek, SP; Lazo, M; Marre, M; McEvoy, JW; Selvin, E; Wang, D; Williams, B; Woodward, M | 1 |
| Lipsky, LM; Nansel, TR; Sanjeevi, N | 1 |
| Daida, H; Dohi, T; Endo, H; Isoda, K; Iwata, H; Kato, Y; Miyauchi, K; Ogita, M; Okai, I; Okazaki, S; Shimada, K; Suwa, S; Takahashi, N; Wada, H | 1 |
| Kiniwa, N; Koga, M; Matsui, H; Matsumura, Y; Okumiya, T; Tokuhiro, S | 1 |
| Colodner, R; Hasanein, J; Hissin, N; Mirsky, N; Nachum, Z; Shwartz, N; Twafra, S; Yefet, E | 1 |
| Brinton, JT; Chan, CL; Nadeau, KJ; Tommerdahl, KL; Vigers, T; Zeitler, PS | 1 |
| Anghebem-Oliveira, MI; Boritza, KC; França, SN; Gomes, LC; Martins, BR; Picheth, G; Rego, FGM; Souza, EM | 1 |
| Bao, Y; He, X; Ma, X; Shen, Y; Su, H; Wang, Y; Ying, L; Zhou, J; Zhu, W | 1 |
| Anzai, N; Fujita, T; Hayashi, K; Kon, H; Morita, A; Oba, K; Ouchi, M; Satoh, K; Shimizu, A; Terada, M; Wakashin, H | 1 |
| Funato, M; Kono, R; Machida, S; Mukai, S; Saito, H; Uchiyama, T | 1 |
| Chen, C; Chen, J; Guo, H; Sun, Z; Tan, Y; Wang, B; Wang, X; Wang, Y; Yang, J; Yuan, Y | 1 |
| Hao, S; Li, H; Li, J; Lou, Q; Miller, JD; Yan, J; Yang, L; Yuan, X; Zuo, P | 1 |
| Bao, Y; Ge, K; Jia, W; Jian, C; Lu, W; Ma, X; Wang, Y; Zhao, A; Zhou, J; Zhu, W | 1 |
| Bao, Y; Lu, J; Lu, W; Ma, X; Shen, Y; Wang, Y; Ying, L; Zhou, J; Zhu, W | 1 |
| Dai, XX; Gao, MX; Shi, GL; Su, G; Yao, WF; Zhang, T; Zhuang, SW | 1 |
| Baly, C; Gabory, A; Jammes, H; Jouin, M; Jouneau, L; Rousseau-Ralliard, D; Safi-Stibler, S; Seyer, A; Thévenot, EA | 1 |
| Ballantyne, CM; Grams, ME; Hoogeveen, RC; Köttgen, A; Lee, AK; Pankow, JS; Selvin, E; Warren, B | 1 |
| Jang, H; Ki, H; Kim, MG; Oh, J | 1 |
| Bao, Y; Hu, G; Lu, J; Lu, W; Ma, X; Mo, Y; Shen, Y; Si, Y; Zhang, L; Zhou, J; Zhu, W | 1 |
| Fujikawa, R; Ito, C; Kira, S; Misumi, M | 1 |
| Dienel, GA | 1 |
| Katsuno, T; Konishi, K; Koyama, H; Kusunoki, Y; Matsuo, T; Matsutani, S; Namba, M; Ohigashi, M; Osugi, K; Tsunoda, T; Washio, K | 1 |
| Bao, YQ; Jian, CH; Lu, W; Ma, XJ; Wang, YF; Zhao, AH; Zhou, J; Zhu, W | 1 |
| Abdel-Hamid, AZ; El-Maraghy, SA; Hanafy, MM; Lindeque, JZ; Shahin, NN | 1 |
| Adamski, J; Artati, A; Federici, M; Ghesquiere, B; Kappel, BA; Lehrke, M; Marx, N; Moellmann, J; Rau, M; Romeo, F; Schuett, K; Stoehr, R; Thiele, K | 1 |
| Hostiuc, M; Hostiuc, S; Negoi, I | 1 |
| Chen, C; Cheng, J; Wang, Y; Yuan, Y | 1 |
| Anzai, N; Fujita, T; Hayashi, K; Kobayashi, S; Kon, H; Morita, A; Oba, K; Ouchi, M; Satoh, K; Sugihara, H; Suzuki, T; Terada, M; Yasutake, M | 1 |
| Hao, M; Huang, X; Li, M; Li, W; Liu, W; Xu, Y; Yan, D | 1 |
| Mitsuke, Y; Morishita, T; Tada, H; Uzui, H | 1 |
| Chałubińska-Fendler, J; Migała, M; Zielińska, M | 1 |
| Alfieri, S; Di Giuseppe, G; Dibner, C; Giaccari, A; Guessous, I; Jiménez-Sánchez, C; Jornayvaz, FR; Li, L; Maechler, P; Mezza, T; Quero, G; Schrauwen, P; Sinturel, F | 1 |
| Chen, W; Dong, J; Ji, F; Li, H; Mu, H; Wang, S; Wang, X; Yang, R; Yu, X; Zhang, W; Zhou, Q | 1 |
26 review(s) available for 1,5-anhydroglucitol and deoxyglucose
| Article | Year |
|---|---|
[Recent progress in evaluation of glycemic control by glycated protein and 1,5-AG].
Topics: Biomarkers; Deoxyglucose; Diabetes Mellitus; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Hexosamines; Humans; Serum Albumin | 1995 |
Serum 1,5-anhydroglucitol (1,5 AG): new clinical marker for glycemic control.
Topics: Biomarkers; Blood Glucose; Colorimetry; Deoxyglucose; Diabetes Mellitus; Gas Chromatography-Mass Spectrometry; Humans; Japan | 1994 |
[Clinical laboratory tests in diabetes mellitus].
Topics: Blood Glucose; Deoxyglucose; Diabetes Mellitus; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Proteinuria | 1994 |
[1,5-Anhydroglucitol (1,5 AG)].
Topics: Aged; Deoxyglucose; Female; Humans; Isomerism | 1995 |
[Screening of glucose intolerance with fasting blood samples].
Topics: Biomarkers; Blood Glucose; Blood Specimen Collection; Clinical Trials as Topic; Deoxyglucose; Diabetes Mellitus; Fasting; Glucose Intolerance; Glycated Hemoglobin; Mass Screening; Risk | 1996 |
[Glycogenolysis through lyase reaction and 1,5-anhydroglucitol].
Topics: Animals; Biomarkers; Cell Membrane Permeability; Cytoplasm; Deoxyglucose; Diabetes Mellitus; Glycogen; Humans; Kidney; Lyases | 1997 |
[1,5-Anhydroglucitol (1,5AG)].
Topics: Biomarkers; Deoxyglucose; Diabetes Mellitus; Gas Chromatography-Mass Spectrometry; Humans; Hypoglycemia; Reference Standards; Sensitivity and Specificity | 1998 |
[1,5-Anhydroglucitol (1,5AG)].
Topics: Deoxyglucose; Female; Humans; Isomerism | 1999 |
[Physiopathology and therapy of diabetes mellitus].
Topics: Animals; Arteriosclerosis; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Humans; Insulin Resistance; Obesity; Patient Education as Topic | 1999 |
1,5-anhydro-D-glucitol: a novel marker of glucose excursions.
Topics: Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Glycated Hemoglobin; Humans; Hyperglycemia; Postprandial Period | 2002 |
[1,5-anhydroglucitol].
Topics: Biomarkers; Blood Glucose; Deoxyglucose; Humans; Hyperglycemia; Postprandial Period; Sensitivity and Specificity | 2002 |
[Laboratory markers for glycemia and their target].
Topics: Biomarkers; Blood Glucose; Clinical Trials as Topic; Deoxyglucose; Diabetes Mellitus; Evidence-Based Medicine; Fructosamine; Glucose; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Ketones; Serum Albumin; Urea | 2002 |
[Problematic issues for diagnosis of diabetes mellitus in the elderly].
Topics: Aged; Biomarkers; Deoxyglucose; Diabetes Mellitus; Glucose Tolerance Test; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Glycosuria; Humans; Serum Albumin | 2002 |
[Diagnosis and tests for impaired glucose tolerance and borderline type].
Topics: Biomarkers; Blood Glucose; Deoxyglucose; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Glycosuria; Humans; Insulin; Serum Albumin | 2005 |
[Plasma anhydro-glucitol as a blood sugar control marker for impared glucose tolerance].
Topics: Biomarkers; Deoxyglucose; Diabetes Mellitus; Glycosuria; Humans; Hyperglycemia; Postprandial Period | 2005 |
[Postprandial hyperglycemia].
Topics: Arteriosclerosis; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 2; Endothelium, Vascular; Evidence-Based Medicine; Glucose; Hyperglycemia; Hyperthyroidism; Insulin; Insulin Resistance; Insulin Secretion; Liver Cirrhosis; Oxidative Stress; Postprandial Period | 2006 |
1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions.
Topics: Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus; Humans; Postprandial Period | 2008 |
1,5-anhydroglucitol monitoring in diabetes: a mass balance perspective.
Topics: Deoxyglucose; Diabetes Mellitus; Humans; Hyperglycemia; Observer Variation; Reproducibility of Results | 2009 |
Assessing postprandial glucose using 1,5-anhydroglucitol: An integrative literature review.
Topics: Adult; Age Factors; Biomarkers; Child; Deoxyglucose; Diabetes, Gestational; Female; Humans; Hyperglycemia; Postprandial Period; Pregnancy; Reference Values; Sensitivity and Specificity | 2009 |
Circulating biomarkers of glycemia in diabetes management and implications for personalized medicine.
Topics: Biomarkers; Deoxyglucose; Diabetes Mellitus; Fructosamine; Glycated Hemoglobin; Humans; Precision Medicine | 2009 |
[Indicators of glycemic control --hemoglobin A1c (HbA1c), glycated albumin (GA), and 1,5-anhydroglucitol (1,5-AG)].
Topics: Biomarkers; Cardiovascular Diseases; Deoxyglucose; Diabetes Complications; Diabetes Mellitus; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Glycemic Index; Humans; Hyperglycemia; Reference Standards; Serum Albumin | 2014 |
1,5-Anhydroglucitol and glycated albumin in glycemia.
Topics: Anemia; Animals; Blood Glucose; Deoxyglucose; Diabetic Nephropathies; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperuricemia; Liver Cirrhosis; Serum Albumin | 2014 |
Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.
Topics: Biomarkers; Blood Glucose; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fasting; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Prognosis; Prospective Studies; Serum Albumin | 2014 |
Beyond self-monitored plasma glucose and HbA1c: the role of non-traditional glycaemic markers in gestational diabetes mellitus.
Topics: Adult; Biomarkers; Blood Glucose; Blood Glucose Self-Monitoring; Deoxyglucose; Diabetes, Gestational; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Maternal Serum Screening Tests; Pregnancy; Serum Albumin | 2018 |
Hypothesis: A Novel Neuroprotective Role for Glucose-6-phosphatase (G6PC3) in Brain-To Maintain Energy-Dependent Functions Including Cognitive Processes.
Topics: Animals; Brain; Deoxyglucose; Enzyme Inhibitors; Glucose-6-Phosphatase; Hexokinase; Hexosephosphates; Humans; Neuroprotection; Phosphorylation; Protein Isoforms | 2020 |
Markers of hyperglycemia in the vitreous humor. A systematic review and meta-analysis.
Topics: 3-Hydroxybutyric Acid; Biomarkers; Deoxyglucose; Forensic Medicine; Fructosamine; Glucose; Humans; Hyperglycemia; Lactic Acid; Postmortem Changes; Vitreous Body | 2021 |
35 trial(s) available for 1,5-anhydroglucitol and deoxyglucose
| Article | Year |
|---|---|
Comparison of 1,5-anhydroglucitol, HbA1c, and fructosamine for detection of diabetes mellitus.
Topics: Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus; Fructosamine; Glucose Tolerance Test; Glycated Hemoglobin; Hexosamines; Humans; Reference Values | 1991 |
1,5-Anhydro-D-glucitol evaluates daily glycemic excursions in well-controlled NIDDM.
Topics: Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Drug Administration Schedule; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Isomerism; Male; Middle Aged; Regression Analysis | 1995 |
Prolonged hyperalimentation as a possible cause of renal tubular dysfunction: evaluation of 1,5-anhydro-D-glucitol resorption and N-acetylglucosaminidase excretion in humans.
Topics: Absorption; Acetylglucosaminidase; Adult; Aged; Aged, 80 and over; Deoxyglucose; Enteral Nutrition; Female; Humans; Kidney Diseases; Kidney Tubules; Male; Middle Aged; Parenteral Nutrition, Total; Time Factors | 1995 |
Effect of aging on plasma 1,5-anhydroglucitol levels in humans and rats.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Animals; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus; Eating; Female; Humans; Isomerism; Male; Middle Aged; Rats; Rats, Wistar; Reference Values; Regression Analysis; Sex Characteristics | 1994 |
A new method of quantitating serum and urinary levels of 1,5-anhydroglucitol in insulin-dependent diabetes mellitus.
Topics: Adolescent; Adult; Biomarkers; Child; Child, Preschool; Chromatography, High Pressure Liquid; Deoxyglucose; Diabetes Mellitus, Type 1; Electrochemistry; Female; Glycosuria; Humans; Indicators and Reagents; Isomerism; Male; Sensitivity and Specificity | 1994 |
Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control.
Topics: Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Administration Schedule; Evaluation Studies as Topic; Female; Follow-Up Studies; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Isomerism; Male; Middle Aged; Prospective Studies; Sensitivity and Specificity; Time Factors | 1996 |
1,5-anhydroglucitol as a marker for the differential diagnosis of acute and chronic renal failure.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Creatinine; Deoxyglucose; Diagnosis, Differential; Female; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged | 1996 |
Predicting long-term glycemic control of post-educational type II diabetic patients by evaluating serum 1,5-anhydroglucitol levels.
Topics: Aged; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Evaluation Studies as Topic; Female; Hospitalization; Humans; Isomerism; Linear Models; Male; Middle Aged; Patient Education as Topic; Prognosis; Time Factors | 1996 |
The influence of traditional Chinese herbal drugs on serum 1, 5-anhydroglucitol levels.
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Female; Humans; Male; Medicine, Kampo; Middle Aged | 2000 |
A double-blind trial on the effects of atorvastatin on glycemic control in Japanese diabetic patients with hypercholesterolemia.
Topics: Adult; Aged; Anticholesteremic Agents; Apolipoproteins; Atorvastatin; Blood Glucose; Cholesterol; Deoxyglucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fructosamine; Glycated Hemoglobin; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Pyrroles | 2001 |
Usefulness of troglitazone administration to obese hyperglycaemic patients with near-normoglycaemia.
Topics: Adult; Aged; Blood Glucose; Chromans; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Male; Middle Aged; Obesity; Thiazoles; Thiazolidinediones; Troglitazone | 2003 |
Effect of antidiabetic medications on microalbuminuria in patients with type 2 diabetes.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Blood Glucose; Cholesterol; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Gliclazide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Thiazolidinediones | 2004 |
Efficacy and safety of once daily gliclazide (20 mg/day) compared with nateglinide.
Topics: Adult; Cross-Over Studies; Cyclohexanes; Deoxyglucose; Diabetes Mellitus, Type 2; Gliclazide; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Lipoproteins, LDL; Malondialdehyde; Nateglinide; Phenylalanine; Prospective Studies; Serum Albumin; Thiobarbituric Acid Reactive Substances | 2004 |
Disproportionately elevated proinsulin levels in type 2 diabetic patients treated with sulfonylurea.
Topics: Aged; Blood Glucose; Body Mass Index; C-Peptide; Caloric Restriction; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fasting; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Multivariate Analysis; Patient Selection; Proinsulin; Sulfonylurea Compounds | 2006 |
Short term intensive insulin therapy improves insulin secretion significantly in type 2 diabetic patients.
Topics: Aged; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Middle Aged; Time Factors; Treatment Outcome | 2006 |
Comparison of pre- vs. postmeal administration of miglitol for 3 months in type 2 diabetic patients.
Topics: 1-Deoxynojirimycin; Analysis of Variance; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Administration Schedule; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Postprandial Period | 2008 |
Randomized trial on the influence of the length of two insulin pen needles on glycemic control and patient preference in obese patients with diabetes.
Topics: Aged; Body Mass Index; Cross-Over Studies; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Injections, Subcutaneous; Insulin; Male; Materials Testing; Middle Aged; Needles; Netherlands; Obesity; Patient Preference; Practice Guidelines as Topic; Self Administration | 2011 |
Effects of miglitol in combination with intensive insulin therapy on blood glucose control with special reference to incretin responses in type 1 diabetes mellitus.
Topics: 1-Deoxynojirimycin; Adult; Aged; Deoxyglucose; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Incretins; Insulin; Male; Middle Aged; Serum Albumin; Weight Loss; Young Adult | 2011 |
Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): crossover pilot study (J-VICTORIA study).
Topics: Adamantane; Adult; Aged; Biomarkers; Blood Glucose; C-Peptide; Cross-Over Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Administration Schedule; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Japan; Male; Middle Aged; Monitoring, Ambulatory; Natriuretic Peptide, Brain; Nitriles; Pilot Projects; Plasminogen Activator Inhibitor 1; Postprandial Period; Predictive Value of Tests; Pyrazines; Pyrrolidines; Serum Albumin; Sitagliptin Phosphate; Time Factors; Treatment Outcome; Triazoles; Vildagliptin | 2012 |
Metabolomic profile of response to supplementation with β-carotene in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study.
Topics: Aged; alpha-Tocopherol; beta Carotene; Blood Glucose; Chromatography, Liquid; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2E1; Deoxyglucose; Dietary Supplements; Double-Blind Method; Fasting; Finland; Follow-Up Studies; Humans; Male; Metabolome; Middle Aged; Risk Factors; Smoking; Tandem Mass Spectrometry | 2013 |
Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy.
Topics: Aged; Asian People; Blood Glucose; Blood Glucose Self-Monitoring; Body Mass Index; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Triazoles | 2013 |
Comparison of the hypoglycemic effect of sitagliptin versus the combination of mitiglinide and voglibose in drug-naïve Japanese patients with type 2 diabetes.
Topics: Aged; Asian People; Blood Glucose; Cross-Over Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Combinations; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Inositol; Insulin; Isoindoles; Male; Middle Aged; Pyrazines; Serum Albumin; Sitagliptin Phosphate; Triazoles | 2013 |
Effect of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, on measurement of serum 1,5-anhydroglucitol.
Topics: Blood Glucose; Canagliflozin; Deoxyglucose; Diabetes Mellitus, Type 2; Double-Blind Method; Follow-Up Studies; Glucosides; Glycated Hemoglobin; Humans; Prognosis; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2014 |
Statins in low doses reduce VEGF and bFGF serum levels in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Cholesterol; Deoxyglucose; Diabetes Mellitus, Type 2; Fibroblast Growth Factor 2; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metformin; Middle Aged; Triglycerides; Vascular Endothelial Growth Factor A | 2014 |
Circulating CD3+56+ cell subset in pre-diabetes.
Topics: Aged; Blood Glucose; CD3 Complex; CD56 Antigen; Deoxyglucose; Diabetes Mellitus, Type 2; Fasting; Glycated Hemoglobin; Humans; Hyperglycemia; Lipids; Male; Middle Aged; Natural Killer T-Cells; Plaque, Atherosclerotic | 2014 |
Low levels of 1,5-anhydro-D-glucitol are associated with vascular endothelial dysfunction in type 2 diabetes.
Topics: Adult; Aged; Biomarkers; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Humans; Male; Middle Aged | 2014 |
Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia - 1,5-anhydroglucitol, fructosamine, and glycated albumin.
Topics: Adolescent; Biomarkers; Child; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Mass Screening; Obesity; Prediabetic State; Serum Albumin | 2016 |
Dose-Finding Quantitative 18F-FDG PET Imaging Study with the Oral Pan-AKT Inhibitor GSK2141795 in Patients with Gynecologic Malignancies.
Topics: Antineoplastic Agents; Biomarkers; Biopsy; Blood Glucose; Deoxyglucose; Diamines; Drug Interactions; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Oncogene Protein v-akt; Positron-Emission Tomography; Pyrazoles; Radiopharmaceuticals; Treatment Outcome | 2015 |
Greater diet quality is associated with more optimal glycemic control in a longitudinal study of youth with type 1 diabetes.
Topics: Adolescent; Blood Glucose; Child; Deoxyglucose; Diabetes Mellitus, Type 1; Diet; Diet Records; Dietary Carbohydrates; Dietary Fats, Unsaturated; Dietary Fiber; Dietary Proteins; Female; Glycated Hemoglobin; Glycemic Index; Humans; Insulin; Longitudinal Studies; Male | 2016 |
Effects of dietary carbohydrate on 1,5-anhydroglucitol in a population without diabetes: results from the OmniCarb trial.
Topics: Adult; Blood Glucose; Cross-Over Studies; Deoxyglucose; Dietary Carbohydrates; Female; Glycemic Index; Humans; Hyperglycemia; Male; Middle Aged; Obesity; Overweight | 2017 |
Efficacy and safety of saxagliptin in combination with insulin in Japanese patients with type 2 diabetes mellitus: a 16-week double-blind randomized controlled trial with a 36-week open-label extension.
Topics: Adamantane; Aged; Blood Glucose; C-Peptide; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptides; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucagon; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Japan; Male; Middle Aged; Placebo Effect; Treatment Outcome | 2017 |
1,5-Anhydroglucitol predicts CKD progression in macroalbuminuric diabetic kidney disease: results from non-targeted metabolomics.
Topics: Albuminuria; Biomarkers; Brazil; Creatinine; Deoxyglucose; Diabetic Nephropathies; Double-Blind Method; Gas Chromatography-Mass Spectrometry; Humans; Metabolomics | 2018 |
Response of 1,5-anhydroglucitol level to intensive glucose- and blood-pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial.
Topics: Aged; Antihypertensive Agents; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Gliclazide; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Intention to Treat Analysis; Male; Microvessels; Middle Aged; Perindopril; Proportional Hazards Models; Risk Factors; Treatment Outcome | 2019 |
Effects of Glucose Fluctuation Targeted Intervention on the Prognosis of Patients with Type 2 Diabetes following the First Episode of Cerebral Infarction.
Topics: Aged; Blood Glucose; Cerebral Infarction; Cholesterol, LDL; Deoxyglucose; Diabetes Mellitus, Type 2; Diet Therapy; Exercise; Female; Functional Status; Glycated Hemoglobin; Glycemic Control; Hand Strength; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Muscle Strength; Patient Care Planning; Postprandial Period; Quality of Life; Treatment Outcome | 2020 |
Association between 1,5-Anhydroglucitol and Acute C Peptide Response to Arginine among Patients with Type 2 Diabetes.
Topics: Adult; Arginine; Biomarkers; Blood Glucose; C-Peptide; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Insulin-Secreting Cells; Male; Middle Aged; Pancreatic Function Tests; Predictive Value of Tests | 2020 |
272 other study(ies) available for 1,5-anhydroglucitol and deoxyglucose
| Article | Year |
|---|---|
Variation in polyol levels in cerebrospinal fluid and serum in diabetic patients.
Topics: Aged; Blood Glucose; Creatinine; Deoxyglucose; Diabetes Mellitus; Diabetic Nephropathies; Ethers, Cyclic; Glucose; Humans; Inositol; Insulin; Middle Aged; Sorbitol; Sugar Alcohols; Uremia | 1975 |
Synthetic reaction of Cellvibrio gilvus cellobiose phosphorylase.
Topics: Binding, Competitive; Deoxyglucose; Glucose; Glucosephosphates; Glucosides; Glucosyltransferases; Gram-Negative Aerobic Bacteria; Kinetics; Substrate Specificity | 1992 |
Distribution of 1,5-anhydro-D-glucitol in normal, diabetic, and perfused rat bodies.
Topics: Animals; Deoxyglucose; Diabetes Mellitus, Experimental; In Vitro Techniques; Intracellular Fluid; Male; Perfusion; Rats; Rats, Sprague-Dawley; Tissue Distribution | 1992 |
Structural requirements of peptide YY for biological activity at enteric sites.
Topics: Animals; Deoxyglucose; Dogs; Female; Gastric Acid; Half-Life; Insulin; Insulin Secretion; Male; Pancreas; Pentagastrin; Peptide Fragments; Peptide YY; Peptides; Sincalide | 1992 |
Interference of maltose in Lana AG kit determination of 1,5-anhydroglucitol and how to avoid it.
Topics: Deoxyglucose; Diabetes Mellitus; False Positive Reactions; Humans; Maltose; Reagent Kits, Diagnostic | 1992 |
Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body.
Topics: Adult; Deoxyglucose; Diabetes Mellitus; Eating; Fasting; Female; Food; Humans; Male; Middle Aged; Polymers; Reference Values | 1992 |
Renal tubular reabsorption of 1,5-anhydro-D-glucitol and D-mannose in vivo in the rat.
Topics: Absorption; Animals; Carbohydrate Metabolism; Deoxyglucose; Furosemide; Kidney Tubules; Kinetics; Male; Mannitol; Mannose; Phlorhizin; Rats; Rats, Inbred Strains | 1992 |
Transport of 1,5-anhydro-D-glucitol into human polymorphonuclear leukocytes.
Topics: 3-O-Methylglucose; Biological Transport; Blood Glucose; Cytochalasin B; Deoxyglucose; Humans; Kinetics; Methylglucosides; Neutrophils | 1992 |
Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus.
Topics: Adult; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Kidney Failure, Chronic; Middle Aged; Renal Dialysis | 1992 |
Estimation of plasma glucose fluctuation with a combination test of hemoglobin A1c and 1,5-anhydroglucitol.
Topics: Adult; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycosuria; Hemoglobin A; Humans; Male; Middle Aged; Osmolar Concentration | 1992 |
Glucose has to be phosphorylated to activate glycogen synthase, but not to inactivate glycogen phosphorylase in hepatocytes.
Topics: Animals; Deoxyglucose; Enzyme Activation; Glucose; Glucosephosphates; Glycogen Synthase; Liver; Male; Phosphorylases; Rats | 1992 |
Secondary 18O isotope effects for hexokinase-catalyzed phosphoryl transfer from ATP.
Topics: Adenosine Triphosphate; Deoxyglucose; Glucose; Hexokinase; Oxygen Isotopes; Substrate Specificity | 1991 |
Serum 1,5-anhydro-D-glucitol and glycemic control in patients with non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Models, Biological; Regression Analysis; Time Factors | 1991 |
[Clinical significance of plasma 1,5-anhydroglucitol analysis in the diagnosis of diabetes mellitus].
Topics: Animals; Blood Glucose; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Experimental; Humans; Kidney; Rats; Reference Values | 1990 |
Mechanism for acute reduction of 1,5-anhydroglucitol in rats treated with diabetogenic agents.
Topics: Alloxan; Animals; Blood Glucose; Deoxy Sugars; Deoxyglucose; Glucose; Glycosuria; Isomerism; Kinetics; Male; Organ Specificity; Rats; Rats, Inbred Strains; Streptozocin | 1990 |
1,5-Anhydro-D-glucitol--a novel type of sugar in the human organism.
Topics: Deoxyglucose; Diabetes Mellitus; Galactosemias; Humans; Isomerism; Molecular Structure | 1990 |
Serum levels of 1,5-anhydro-D-glucitol during the normal and diabetic pregnancy and puerperium.
Topics: Blood Glucose; Deoxyglucose; Female; Glucose Tolerance Test; Hemoglobin A; Humans; Isomerism; Postpartum Period; Pregnancy; Pregnancy in Diabetics | 1990 |
Plasma 1,5-anhydroglucitol in experimental galactosemia in the rat.
Topics: Animals; Deoxy Sugars; Deoxyglucose; Fructose; Galactose; Galactosemias; Glucose; Rats; Rats, Inbred Strains; Xylose | 1990 |
[Diabetes markers (1)--with special reference to alpha(1)-microglobulin, beta(2)-microglobulin, N-acetyl glucosaminidase, myoinositol and 1,5-anhydroglucitol].
Topics: Acetylglucosaminidase; Alpha-Globulins; beta 2-Microglobulin; Deoxy Sugars; Deoxyglucose; Diabetes Mellitus; Hexosaminidases; Humans; Inositol; Serum Globulins | 1986 |
[New diagnostic tests for diabetes mellitus. 1,5-anhydroglucitol].
Topics: Blood Glucose; Deoxy Sugars; Deoxyglucose; Diabetes Mellitus; Female; Humans; Male; Reference Values | 1989 |
[Significance of 1,5-anhydroglucitol analysis in clinical tests].
Topics: Blood Glucose; Chromatography, Gas; Deoxy Sugars; Deoxyglucose; Diabetes Mellitus; Humans; Reference Values; Specimen Handling; Spectrophotometry | 1989 |
Plasma 1,5-anhydro-D-glucitol as new clinical marker of glycemic control in NIDDM patients.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Deoxy Sugars; Deoxyglucose; Diabetes Mellitus, Type 2; Fasting; Female; Glycosuria; Humans; Insulin; Male; Middle Aged; Pregnancy; Pregnancy in Diabetics | 1989 |
Changes in relationship between blood glucose level and plasma 1,5-anhydroglucitol level in KK mice.
Topics: Animals; Blood Glucose; Deoxy Sugars; Deoxyglucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Insulin Resistance; Mice; Mice, Inbred Strains | 1989 |
Simple enzymatic method for determining 1,5-anhydro-D-glucitol in plasma for diagnosis of diabetes mellitus.
Topics: Benzothiazoles; Carbohydrate Dehydrogenases; Chromatography, Gas; Deoxy Sugars; Deoxyglucose; Diabetes Mellitus; Humans; Spectrophotometry; Sulfonic Acids | 1989 |
Isolation and characterization of the discrete N- and C-terminal halves of rat brain hexokinase: retention of full catalytic activity in the isolated C-terminal half.
Topics: Amino Acid Sequence; Animals; Brain; Catalysis; Chromatography, Affinity; Deoxyglucose; Hexokinase; Hydrolysis; Molecular Weight; Peptide Fragments; Phosphates; Protein Denaturation; Rats; Structure-Activity Relationship; Triazines | 1989 |
Marked depletion of plasma 1,5-anhydroglucitol, a major polyol, in streptozocin-induced diabetes in rats and the effect of insulin treatment.
Topics: Animals; Blood Glucose; Chromatography, Gas; Deoxy Sugars; Deoxyglucose; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Humans; Insulin; Male; Rats; Rats, Inbred Strains; Streptozocin; Time Factors; Tissue Distribution | 1986 |
Urinary excretion of 1,5-anhydro-D-glucitol accompanying glucose excretion in diabetic patients.
Topics: Adult; Deoxy Sugars; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glycosuria; Humans; Isomerism; Reference Values | 1988 |
Transport of 1,5-anhydro-D-glucitol across plasma membranes in rat hepatoma cells.
Topics: Animals; Binding, Competitive; Biological Transport, Active; Cell Membrane; Cytochalasin B; Deoxy Sugars; Deoxyglucose; Kinetics; Liver Neoplasms, Experimental; Phloretin; Phlorhizin; Rats; Tumor Cells, Cultured | 1988 |
Reduction of plasma 1,5-anhydroglucitol (1-deoxyglucose) concentration in diabetic patients.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Creatinine; Deoxy Sugars; Deoxyglucose; Diabetes Mellitus; Female; Humans; Isomerism; Liver Diseases; Male; Middle Aged; Obesity; Sex Factors | 1988 |
Reduced renal reabsorption of 1,5-anhydro-D-glucitol in diabetic rats and mice.
Topics: Absorption; Animals; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Deoxy Sugars; Deoxyglucose; Diabetes Mellitus, Experimental; Gas Chromatography-Mass Spectrometry; Glycosuria; Kidney; Male; Mice; Mice, Inbred ICR; Rats; Rats, Inbred Strains; Tissue Distribution | 1987 |
Reduction and recovery of plasma 1,5-anhydro-D-glucitol level in diabetes mellitus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Blood Glucose; C-Peptide; Deoxy Sugars; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Longitudinal Studies; Male; Middle Aged; Rats | 1987 |
1-Deoxyglucose (1,5-anhydro-D-glucitol) concentration during pregnancy and puerperium.
Topics: Deoxy Sugars; Deoxyglucose; Female; Humans; Postpartum Period; Pregnancy; Pregnancy in Diabetics; Reference Values | 1987 |
Oxidation of 1,5-anhydro-D-glucitol to 1,5-anhydro-D-fructose catalyzed by an enzyme from bacterial membranes.
Topics: Cell Membrane; Chemical Phenomena; Chemistry; Deoxy Sugars; Deoxyglucose; Fructose; Magnetic Resonance Spectroscopy; Oxidation-Reduction; Oxidoreductases; Pseudomonas; Substrate Specificity | 1986 |
Sugar transport in Trypanosoma brucei: a suitable kinetic probe.
Topics: Animals; Binding, Competitive; Biological Transport; Carbohydrate Metabolism; Deoxyglucose; Glucose; Hexokinase; Kinetics; Trypanosoma brucei brucei | 1986 |
Structural evaluation of anorectic action induced by 1,5-anhydro-D-glucitol.
Topics: Animals; Appetite Depressants; Body Weight; Brain; Darkness; Deoxy Sugars; Deoxyglucose; Drinking; Drinking Behavior; Eating; Feeding Behavior; Fucose; Glucose; Male; Rats; Rats, Inbred Strains; Rhamnose; Structure-Activity Relationship | 1985 |
Identification of 1,5-anhydroglucitol in thin-layer chromatograms.
Topics: Chemical Phenomena; Chemistry; Chromatography, Thin Layer; Deoxyglucose; Mass Spectrometry; Oxidation-Reduction; Periodic Acid; Sorbitol; Spectrophotometry, Infrared | 1980 |
Feeding suppression induced by intra-ventricle III infusion of 1,5-anhydroglucitol.
Topics: Animals; Chromatography, Gas; Deoxy Sugars; Deoxyglucose; Eating; Injections, Intraventricular; Ion Channels; Isomerism; Male; Rats; Rats, Inbred Strains; Sodium; Structure-Activity Relationship; Time Factors | 1983 |
Routine screening for prostatic cancer by assay of serum acid phosphatase: a modest proposal.
Topics: Chromatography, Gas; Deoxy Sugars; Deoxyglucose; Diabetes Mellitus, Type 1; Humans; Insulin | 1984 |
Serum 1,5-anhydroglucitol concentration in diabetic patients receiving a continuous subcutaneous infusion of insulin.
Topics: Chromatography, Gas; Deoxy Sugars; Deoxyglucose; Diabetes Mellitus, Type 1; Humans; Insulin | 1984 |
Aromatic and heterocyclic 1-C-substituted derivatives of 1,5-anhydro-D-glucitol.
Topics: Deoxy Sugars; Deoxyglucose; Magnetic Resonance Spectroscopy | 1984 |
The elimination of 1,5-anhydroglucitol administered to rats.
Topics: Animals; Deoxy Sugars; Deoxyglucose; Metabolic Clearance Rate; Rats | 1984 |
Serum 1,5-anhydroglucitol in normal subjects and in patients with insulin-dependent diabetes mellitus.
Topics: Adolescent; Adult; Chromatography, Gas; Chromatography, Thin Layer; Deoxy Sugars; Deoxyglucose; Diabetes Mellitus; Female; Humans; Insulin; Male; Mass Spectrometry; Middle Aged | 1982 |
Identification and metabolic implication of 1-deoxyglucose (1,5-anhydroglucitol) in human plasma.
Topics: Adolescent; Adult; Blood Glucose; Child; Child, Preschool; Deoxy Sugars; Deoxyglucose; Fetal Blood; Gas Chromatography-Mass Spectrometry; Humans; Infant; Infant, Newborn; Reference Values | 1982 |
Reduced levels of plasma 1,5-anhydroglucitol in diabetic patients.
Topics: Blood Glucose; Chromatography, High Pressure Liquid; Deoxyglucose; Diabetes Mellitus; Glycerol; Humans; Reference Values; Sorbitol; Spectrometry, Fluorescence | 1981 |
Feeding and hyperglycemia induced by 1,5-anhydroglucitol in the rat.
Topics: Adrenal Medulla; Animals; Blood Glucose; Deoxyglucose; Dose-Response Relationship, Drug; Drinking Behavior; Feeding Behavior; Glucose; Hyperglycemia; Injections, Intraventricular; Male; Rats; Rats, Inbred Strains; Sorbitol | 1981 |
Authentic standards for the reductive-cleavage method. The positional isomers of partially methylated and acetylated or benzoylated 1,5-anhydro-D-glucitol.
Topics: Acetates; Acetylation; Benzoates; Carbohydrate Conformation; Chromatography, Gas; Deoxyglucose; Isomerism; Magnetic Resonance Spectroscopy; Mass Spectrometry; Methylation; Molecular Structure; Oxidation-Reduction; Reference Standards; Sorbitol | 1995 |
Comparison of micro-enzymatic and high-performance liquid chromatographic methods for the assay of serum 1,5-anhydroglucitol.
Topics: Blood Chemical Analysis; Blood Glucose; Carbohydrate Dehydrogenases; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Deoxyglucose; Diabetes Mellitus; Horseradish Peroxidase; Humans; Hydrogen Peroxide; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry | 1995 |
Serum 1,5-anhydro-D-glucitol assay by high performance anion exchange chromatography.
Topics: Blood Glucose; Chromatography, High Pressure Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Humans; Reference Values; Specimen Handling | 1994 |
[Significance of 1,5-anhydro-D-glucitol in diabetes mellitus management].
Topics: Adult; Deoxyglucose; Diabetes Mellitus; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Male; Middle Aged | 1994 |
1,5-Anhydroglucitol: a novel serum marker for screening and monitoring diabetes mellitus?
Topics: Animals; Biomarkers; Deoxyglucose; Diabetes Mellitus; Humans | 1994 |
Fully automated flow-injection system for quantifying 1,5-anhydro-D-glucitol in serum.
Topics: Autoanalysis; Carbohydrate Dehydrogenases; Colorimetry; Deoxyglucose; Diabetes Mellitus; Flow Injection Analysis; Gas Chromatography-Mass Spectrometry; Horseradish Peroxidase; Humans; Hydrogen Peroxide; Sensitivity and Specificity | 1994 |
Fully enzymatic method for determining 1,5-anhydro-D-glucitol in serum.
Topics: Adenosine Triphosphate; Autoanalysis; Carbohydrate Dehydrogenases; Colorimetry; Deoxyglucose; Glucokinase; Humans; Hydrogen Peroxide; Phosphoenolpyruvate; Pyruvate Kinase; Quality Control; Sensitivity and Specificity | 1994 |
Enzymatic quantification of 1,5-anhydro-D-glucitol: evaluation and clinical application.
Topics: Adult; Aged; Aged, 80 and over; Aging; Blood Proteins; Body Mass Index; Chromatography, Ion Exchange; Deoxyglucose; Diabetes Mellitus; Female; Glucose Tolerance Test; Hemolysis; Humans; Reference Values; Sensitivity and Specificity | 1994 |
Simultaneous determination of glucose and 1-deoxyglucose in serum by anion-exchange chromatography with an immobilized pyranose oxidase reactor.
Topics: Anions; Blood Glucose; Carbohydrate Dehydrogenases; Chromatography, Ion Exchange; Deoxyglucose; Drug Stability; Enzymes, Immobilized; Ferricyanides; Humans; Hydrogen Peroxide; Luminescent Measurements; Luminol; Reproducibility of Results; Sensitivity and Specificity | 1993 |
Transport and accumulation of 1,5-anhydro-D-glucitol in the human erythroleukemia cell line K-562.
Topics: Biological Transport; Cell Line; Cytochalasin B; Deoxyglucose; Humans; Isomerism; Kinetics; Leukemia, Erythroblastic, Acute; Monosaccharides; Phloretin; Phlorhizin; Time Factors; Tumor Cells, Cultured | 1994 |
Synthesis of 1,5-anhydro-D-glucitol from glucose in rat hepatoma cells.
Topics: Animals; Deoxyglucose; Dietary Carbohydrates; Gas Chromatography-Mass Spectrometry; Glucose; Liver Neoplasms, Experimental; Rats; Time Factors; Tumor Cells, Cultured | 1994 |
Conditional synthesis and utilization of 1,5-anhydroglucitol in Escherichia coli.
Topics: Biological Transport; Carbon Isotopes; Cyclic AMP; Deoxyglucose; Escherichia coli; Gas Chromatography-Mass Spectrometry; Glucose; Isomerism; Kinetics | 1993 |
Effects of 1,5-anhydro-D-fructose on selected glucose-metabolizing enzymes.
Topics: Aspergillus niger; Carbohydrate Dehydrogenases; Carbohydrate Epimerases; Deoxyglucose; Fructose; Glucokinase; Glucose; Hexokinase; Hydrolysis; Magnetic Resonance Spectroscopy; Phosphorylation; Spectrometry, Mass, Fast Atom Bombardment | 1993 |
Quantification of serum 1,5-anhydroglucitol in uremic and diabetic patients by liquid chromatography/mass spectrometry.
Topics: Adult; Aged; Aged, 80 and over; Chromatography, Liquid; Deoxyglucose; Diabetes Mellitus; Female; Fructosamine; Hexosamines; Humans; Inositol; Male; Mass Spectrometry; Middle Aged; Reference Values; Renal Dialysis; Uremia | 1994 |
[Clinical markers in endocrine-metabolic diseases].
Topics: Biomarkers; Collagen; Deoxyglucose; Diabetes Mellitus; Endocrine System Diseases; Female; Humans; Hyperthyroidism; Male | 1993 |
[Efficacy of hemoglobin-Alc, fructosamine, and 1,5-anhydroglucitol in community screening for diabetes mellitus].
Topics: Adult; Aged; Aged, 80 and over; Community Health Services; Deoxyglucose; Diabetes Mellitus; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Male; Mass Screening; Middle Aged | 1993 |
Phosphorylation of 1,5-anhydro-D-glucitol in mammalian cells.
Topics: Animals; Deoxyglucose; Glucose; Humans; Male; Phosphorylation; Rats; Rats, Wistar; Tumor Cells, Cultured | 1995 |
Common reabsorption system of 1,5-anhydro-D-glucitol, fructose, and mannose in rat renal tubule.
Topics: Absorption; Animals; Blood Glucose; Carbohydrates; Deoxyglucose; Fructose; Glycosuria; Kidney Tubules; Male; Mannose; Monosaccharide Transport Proteins; Rats; Rats, Wistar | 1996 |
Production of 1,5-anhydroglucitol from 1,5-anhydrofructose in erythroleukemia cells.
Topics: Animals; Cell Line; Chromatography, Ion Exchange; Deoxyglucose; Fructose; Glucose; Glycolysis; Humans; Kinetics; Leukemia, Erythroblastic, Acute; Mammals; Mass Spectrometry; Molecular Structure; Sorbitol; Tumor Cells, Cultured | 1996 |
Mannose, mannitol, fructose and 1,5-anhydroglucitol concentrations measured by gas chromatography/mass spectrometry in blood plasma of diabetic patients.
Topics: Blood Glucose; Creatinine; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructose; Gas Chromatography-Mass Spectrometry; Humans; Isomerism; Mannitol; Mannose | 1996 |
Effects of age and obesity on glycated haemoglobin and 1,5-anhydroglucitol in screening for type 2 diabetes mellitus.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Biomarkers; Body Mass Index; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; False Positive Reactions; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Japan; Mass Screening; Middle Aged; Multivariate Analysis; Obesity; Probability; Regression Analysis; Reproducibility of Results; Rural Population; Stereoisomerism | 1995 |
[False-positive increase in 1,5-anhydro-D-glucitol due to Kampo (Japanese herbal) medicine].
Topics: Aged; Aged, 80 and over; Biomarkers; Deoxyglucose; Diabetes Mellitus; Drugs, Chinese Herbal; False Positive Reactions; Humans; Male | 1996 |
Lymphocyte activation effect of (1-->6)-2,5-anhydro-D-glucitol and it derivatives with 3,4-di-O-methyl and sulfate groups.
Topics: Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Division; Cells, Cultured; Deoxyglucose; Fibroblasts; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Polysaccharides; Spleen; Structure-Activity Relationship | 1996 |
Proteinuria and plasma hexosugars in early-stage glomerulonephritis.
Topics: Adult; Cholesterol; Deoxyglucose; Gas Chromatography-Mass Spectrometry; Glomerulonephritis; Hexoses; Humans; Hyperlipidemias; Proteinuria; Triglycerides | 1996 |
Decreased serum 1,5-anhydroglucitol in nondiabetic subjects with a family history of NIDDM.
Topics: Analysis of Variance; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Glycosuria; Humans; Isomerism; Middle Aged; Nuclear Family; Reference Values | 1996 |
Escherichia coli phosphorylates 1,5-Anhydroglucitol and releases 1,5-Anhydroglucitol 6-phosphate when glucose is absent in the medium.
Topics: Binding Sites; Biological Transport; Cell Membrane; Culture Media; Deoxyglucose; Escherichia coli; Glucose; Hexosephosphates; Magnetic Resonance Spectroscopy; Mass Spectrometry; Phosphorylation; Time Factors | 1996 |
NMR of all-carbon-13 sugars: an application in development of an analytical method for a novel natural sugar, 1,5-anhydrofructose.
Topics: Animals; Carbon Isotopes; Deoxyglucose; Fructose; Liver; Magnetic Resonance Spectroscopy; Mass Spectrometry; Oxidation-Reduction; Rats | 1996 |
Plasma 1,5-anhydro-D-glucitol concentration and its relation to other plasma components in renal failure and renal transplant recipients.
Topics: Adult; Aged; Blood Chemical Analysis; Deoxyglucose; Female; Humans; Kidney Transplantation; Male; Middle Aged; Renal Insufficiency | 1996 |
Na(+)-dependent uptake of 1,5-anhydro-D-glucitol via the transport systems for D-glucose and D-mannose in the kidney epithelial cell line, LLC-PK1.
Topics: Animals; Biological Transport; Deoxyglucose; Epithelial Cells; Epithelium; Glucose; Humans; Kidney; LLC-PK1 Cells; Mannose; Microvilli; Sodium; Stereoisomerism; Swine | 1996 |
Effect of acarbose on blood glucose profiles and plasma 1,5-anhydro-d-glucitol in type 2 diabetes poorly controlled by sulfonylurea therapy.
Topics: Acarbose; Aged; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glucose Tolerance Test; Glyburide; Glycosuria; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Trisaccharides | 1996 |
Purification of a marine bacterial glucose dehydrogenase from Cytophaga marinoflava and its application for measurement of 1,5-anhydro-D-glucitol.
Topics: Chromatography; Cytophaga; Deoxyglucose; Glucose 1-Dehydrogenase; Glucose Dehydrogenases | 1996 |
Hepatic production of 1,5-anhydrofructose and 1,5-anhydroglucitol in rat by the third glycogenolytic pathway.
Topics: Animals; Deoxyglucose; Fructose; Gas Chromatography-Mass Spectrometry; Glucans; Glycogen; Male; Methods; Oxidation-Reduction; Oximes; Rats; Rats, Wistar; Tissue Distribution | 1996 |
Change of plasma 1,5-anhydro-D-glucitol levels after the onset of diabetes in spontaneous diabetes prone BB/Wor/(/)Tky rats.
Topics: Animals; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus; Glycosuria; Rats; Rats, Inbred Strains; Sensitivity and Specificity | 1997 |
Rapid improvement of serum 1,5-anhydroglucitol concentrations after administration of alpha-glucosidase inhibitor.
Topics: Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Inositol; Isomerism; Male; Middle Aged | 1997 |
Post-column enzyme reactors for chemiluminometric detection of glucose, 1,5-anhydroglucitol and 3-hydroxybutyrate in an anion-exchange chromatographic system.
Topics: 3-Hydroxybutyric Acid; Blood Glucose; Calibration; Chromatography, Ion Exchange; Deoxyglucose; Humans; Hydroxybutyrates; Luminescent Measurements | 1997 |
Quantification of 1,5-anhydro-D-glucitol in urine by automated borate complex anion-exchange chromatography with an immobilized enzyme reactor.
Topics: Borates; Chromatography, Gas; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Deoxyglucose; Enzymes, Immobilized; Humans; Mass Spectrometry | 1997 |
A kinetic mass balance model for 1,5-anhydroglucitol: applications to monitoring of glycemic control.
Topics: Blood Glucose; Deoxyglucose; Diabetes Mellitus; Glomerular Filtration Rate; Glycosuria; Homeostasis; Humans; Hyperglycemia; Isomerism; Kidney; Kinetics; Models, Biological | 1997 |
[Clinical evaluation of serum 1,5AG levels in patients with liver cirrhosis].
Topics: Collagen; Deoxyglucose; Diabetes Mellitus; Humans; Liver Cirrhosis | 1997 |
Decreased activity of arachidonate 12-lipoxygenase in platelets of Japanese patients with non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Arachidonate 12-Lipoxygenase; Arachidonic Acid; Blood Glucose; Blood Platelets; Body Mass Index; Cytosol; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Fructose; Glucose; Glycated Hemoglobin; Humans; Male; Middle Aged; Sex Characteristics | 1998 |
Mechanisms of elevation of serum and urinary concentrations of soluble thrombomodulin in diabetic patients: possible application as a marker for vascular endothelial injury.
Topics: Adult; Albuminuria; beta 2-Microglobulin; Blood Glucose; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Solubility; Thrombomodulin | 1998 |
Different effects of acarbose and voglibose on serum 1,5-anhydroglucitol concentrations.
Topics: Acarbose; Aged; Deoxyglucose; Enzyme Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Inositol; Male; Middle Aged; Trisaccharides | 1998 |
Acute glucosuria after continuous glucocorticoid loading in the rat in vivo.
Topics: Animals; Blood Glucose; Deoxyglucose; Dexamethasone; Dose-Response Relationship, Drug; Estradiol; Glucocorticoids; Glycosuria; Infusions, Intravenous; Insulin; Male; Progesterone; Rats; Rats, Wistar | 1998 |
Relationship between serum 1,5-anhydroglucitol and urinary excretion of N-acetylglucosaminidase and albumin determined at onset of NIDDM with 3-year follow-up.
Topics: Acetylglucosaminidase; Adult; Albuminuria; Biomarkers; Blood Glucose; Blood Pressure; Blood Proteins; Cholesterol; Cholesterol, HDL; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Follow-Up Studies; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Isomerism; Male; Middle Aged; Prospective Studies; Regression Analysis; Sulfonylurea Compounds; Time Factors; Triglycerides | 1998 |
Serum 1,5-anhydro-D-glucitol levels in liver cirrhosis.
Topics: Cholinesterases; Deoxyglucose; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Osmolar Concentration; Reference Values; Serum Albumin | 1998 |
Insulin-like growth factors - insulin-like growth factor binding protein axis and diabetic control in insulin-dependent diabetes mellitus.
Topics: Adolescent; Adult; Blood Glucose; Child; Child, Preschool; Deoxyglucose; Diabetes Mellitus, Type 1; Female; Fructosamine; Humans; Insulin-Like Growth Factor Binding Proteins; Male; Somatomedins | 1998 |
1,5-Anhydroglucitol promotes glycogenolysis in Escherichia coli.
Topics: Carbohydrate Sequence; Deoxyglucose; Escherichia coli; Fructose; Glycogen; Hexosephosphates; Molecular Sequence Data | 1999 |
Renal tubular function affects glycosuria-related urinary excretion of 1,5-anhydroglucitol.
Topics: Aged; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus; Female; Glucose Tolerance Test; Glycosuria; Humans; Isomerism; Kidney Tubules; Male | 1999 |
Plasma 1,5-anhydroglucitol concentrations are influenced by variations in the renal threshold for glucose.
Topics: Adult; Blood Glucose; Deoxyglucose; Female; Gestational Age; Glucose; Glucose Tolerance Test; Glycosuria; Humans; Kidney; Kinetics; Pregnancy; Pregnancy in Diabetics | 1999 |
Economic evaluation of alternative indicators for screening for diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Deoxyglucose; Diabetes Mellitus, Type 2; Fructosamine; Glucose Intolerance; Glycated Hemoglobin; Humans; Male; Mass Screening; Middle Aged; Models, Econometric; Sensitivity and Specificity | 1999 |
Serum concentration and renal handling of 1,5-anhydro-D-glucitol in patients with chronic renal failure.
Topics: Biomarkers; Deoxyglucose; Glucose; Humans; Kidney; Kidney Failure, Chronic | 1999 |
Transport of 1,5-anhydro-D-glucitol into insulinoma cells by a glucose-sensitive transport system.
Topics: Carbon Radioisotopes; Deoxyglucose; Dose-Response Relationship, Drug; Glucose; Humans; Insulinoma; Kinetics; Monosaccharide Transport Proteins; Pancreatic Neoplasms; Temperature; Tritium; Tumor Cells, Cultured | 2000 |
Enzyme electrochemical preparation of a 3-keto derivative of 1,5-anhydro-D-glucitol using glucose-3-dehydrogenase.
Topics: Biomarkers; Deoxyglucose; Diabetes Mellitus; Electrochemistry; Glucose 1-Dehydrogenase; Glucose Dehydrogenases; Halomonas; Humans; Molecular Structure; Seawater; Sorbitol | 2000 |
Increases in 1,5-anhydroglucitol levels in germinating amaranth seeds and in ripening banana.
Topics: Deoxyglucose; Germination; Magnoliopsida; Seeds; Starch; Zingiberales | 2000 |
The predictive value of serum 1,5-anhydro-D-glucitol in pregnancies at increased risk of gestational diabetes mellitus and gestational impaired glucose tolerance.
Topics: Adolescent; Adult; Antimetabolites; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes, Gestational; Female; Glucose Intolerance; Glucose Tolerance Test; Humans; Middle Aged; Predictive Value of Tests; Pregnancy; Sensitivity and Specificity | 2001 |
Post-load glucose measurements in oral glucose tolerance tests correlate well with 1,5-anhydroglucitol, an indicator of overall glycaemic state, in subjects with impaired glucose tolerance.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Cross-Sectional Studies; Deoxyglucose; Female; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Longitudinal Studies; Male; Middle Aged | 2001 |
Serum 1,5-anhydro-D-glucitol as a new clinical marker for glucose metabolism in type 2 diabetics.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose; Humans; Male; Middle Aged | 1999 |
Clinical application of the serum 1,5-anhydroglucitol assay method using glucose 3-dehydrogenase.
Topics: Blood Chemical Analysis; Deoxyglucose; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Glucose Dehydrogenases; Humans; Plasma; Reproducibility of Results; Tetrazolium Salts | 2002 |
A novel NAD-dependent dehydrogenase, highly specific for 1,5-anhydro-D-glucitol, from Trichoderma longibrachiatum strain 11-3.
Topics: Deoxyglucose; Diabetes Mellitus; Enzyme Stability; Humans; Hydrogen-Ion Concentration; Kinetics; Molecular Weight; Soil Microbiology; Substrate Specificity; Sugar Alcohol Dehydrogenases; Temperature; Trichoderma | 2003 |
Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker.
Topics: Biomarkers; Blood Glucose; Deoxyglucose; Environmental Monitoring; Gas Chromatography-Mass Spectrometry; Humans; Hyperglycemia; Isomerism; Japan | 2003 |
MUTAROTASE INHIBITION BY 1-DEOXYGLUCOSE.
Topics: Animals; Biological Transport; Carbohydrate Epimerases; Cricetinae; Deoxyglucose; Enzyme Inhibitors; Glucose; Hexoses; Humans; Intestines; Isomerases; Research | 1964 |
1,5-Anhydroglucitol stimulates insulin release in insulinoma cell lines.
Topics: Animals; Carbohydrates; Cell Division; Cell Line, Tumor; Deoxyglucose; Humans; Insulin; Insulin Secretion; Insulinoma; Pancreatic Neoplasms; Xylitol | 2003 |
B3LYP/6-311++G** study of alpha- and beta-D-glucopyranose and 1,5-anhydro-D-glucitol: 4C1 and 1C4 chairs, (3,O)B and B(3,O) boats, and skew-boat conformations.
Topics: Carbohydrate Conformation; Computer Simulation; Deoxyglucose; Glucose; Hydrogen Bonding; Models, Molecular; Thermodynamics | 2004 |
Long-term exercise down-regulates leptin receptor mRNA in the arcuate nucleus.
Topics: Adipose Tissue; Animals; Arcuate Nucleus of Hypothalamus; Deoxyglucose; Down-Regulation; Glucose; Insulin Resistance; Leptin; Male; Muscle, Skeletal; Physical Conditioning, Animal; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, Leptin; RNA, Messenger; Time | 2004 |
Postprandial plasma fructose level is associated with retinopathy in patients with type 2 diabetes.
Topics: Aged; Blood Glucose; Blood Pressure; Body Mass Index; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Female; Fructose; Glycated Hemoglobin; Humans; Male; Middle Aged; Postprandial Period; Prevalence | 2004 |
Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay.
Topics: Adult; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Longitudinal Studies; Time Factors | 2004 |
Evaluation of an assay for serum 1,5-anhydroglucitol (GlycoMark) and determination of reference intervals on the Hitachi 917 analyzer.
Topics: Adolescent; Autoanalysis; Bilirubin; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus; Ethnicity; Female; Hemoglobins; Humans; Hyperglycemia; Immunoassay; Male; Temperature; Triglycerides | 2004 |
SLC5A9/SGLT4, a new Na+-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-D-glucitol, and fructose.
Topics: Amino Acid Sequence; Animals; COS Cells; Deoxyglucose; Fructose; Humans; Mannose; Molecular Sequence Data; Monosaccharide Transport Proteins; RNA, Messenger; Sodium-Glucose Transporter 2 | 2005 |
[1,5-anhydroglucitol].
Topics: Deoxyglucose; Female; Humans; Hyperglycemia | 2004 |
The application of plasma 1,5-anhydro-D-glucitol for monitoring type 2 diabetic patients.
Topics: Adult; Aged; Blood Glucose; Blood Glucose Self-Monitoring; Cardiovascular System; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose; Glycated Hemoglobin; Humans; Male; Middle Aged; Multivariate Analysis; Regression Analysis | 2005 |
Fluctuations in glycaemia in clinical diabetes mellitus type 2 are not associated with carotid intima-media thickening.
Topics: Blood Glucose; Carotid Artery, Common; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hyperglycemia; Middle Aged; Tunica Intima; Tunica Media; Ultrasonography | 2004 |
Plasma anhydro-D-glucitol (1,5-AG) as an indicator of hyperglycaemic excursions in pregnant women with diabetes.
Topics: Adolescent; Adult; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes, Gestational; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Pregnancy; Pregnancy in Diabetics | 2006 |
Serum uric acid concentrations in type 2 diabetes: its significant relationship to serum 1,5-anhydroglucitol concentrations.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; Cholesterol; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Glycated Hemoglobin; Humans; Linear Models; Male; Middle Aged; Sex Characteristics; Uric Acid | 2005 |
Current advances in research that affect patient care.
Topics: Administration, Inhalation; Adult; Blood Glucose; Blood Glucose Self-Monitoring; Bone Density Conservation Agents; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diphosphonates; Female; Fractures, Spontaneous; Humans; Hypoglycemic Agents; Insulin; Jaw Diseases; Middle Aged; Osteonecrosis; Osteoporosis | 2006 |
1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes.
Topics: Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Humans; Hyperglycemia; Monitoring, Ambulatory; Monitoring, Physiologic; Postprandial Period; Reproducibility of Results | 2006 |
Hyperglycemia and diabetic renal change in a model of polyvinyl alcohol bioartificial pancreas transplantation.
Topics: Animals; Bioartificial Organs; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gels; Glomerular Mesangium; Hyperglycemia; Insulin; Islets of Langerhans; Kidney Function Tests; Linear Models; Male; Mice; Mice, Inbred C57BL; Pancreas Transplantation; Pancreas, Artificial; Polyvinyl Alcohol; Rats; Rats, Wistar; Severity of Illness Index; Time Factors; Tissue Culture Techniques; Tissue Engineering; Transplantation, Heterologous | 2007 |
Pro-atherogenic alterations in T-lymphocyte subpopulations related to acute hyperglycaemia in type 2 diabetic patients.
Topics: Acute Disease; Aged; Antigens, CD; Blood Glucose; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Coronary Artery Disease; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fasting; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Lipids; Lymphocyte Count; Male; Middle Aged; Risk Factors; Tunica Intima | 2007 |
Serum 1,5-anhydroglucitol (Glycomark) levels in children with and without type 1 diabetes mellitus.
Topics: Adolescent; Biomarkers; Blood Glucose; Child; Deoxyglucose; Diabetes Mellitus, Type 1; Female; Glycated Hemoglobin; Humans; Male; Reference Values | 2007 |
A novel fully enzymatic method for determining glucose and 1,5-anhydro-D-glucitol in serum of one cuvette.
Topics: Blood Glucose; Chemistry Techniques, Analytical; Deoxyglucose; Diabetes Mellitus, Type 2; Glucokinase; Glucosephosphate Dehydrogenase; Humans; Models, Biological; Reproducibility of Results | 2008 |
IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; C-Peptide; Coronary Artery Disease; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Interleukin-12; Lipoproteins, HDL; Male; Middle Aged; Multivariate Analysis; Proinsulin; Regression Analysis; Sulfonylurea Compounds | 2008 |
Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients.
Topics: Aged; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Fasting; Humans; Hypoglycemic Agents; Middle Aged; Outpatients; Postprandial Period; Reproducibility of Results; Switzerland | 2008 |
Clinical application of 1,5-anhydroglucitol measurements in patients with hepatocyte nuclear factor-1alpha maturity-onset diabetes of the young.
Topics: Adult; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Hepatocyte Nuclear Factor 1-alpha; Humans; Male; Middle Aged; Mutation; Poland; Reference Values; Registries; Sex Characteristics | 2008 |
A novel method for the determination of 1,5-anhydroglucitol, a glycemic marker, in human urine utilizing hydrophilic interaction liquid chromatography/MS(3).
Topics: Biomarkers; Chromatography, High Pressure Liquid; Deoxyglucose; Diabetes Mellitus; Female; Humans; Male; Mass Spectrometry; Sensitivity and Specificity | 2008 |
Determination of glycemic monitoring marker 1,5-anhydroglucitol in plasma by liquid chromatography-electrospray tandem mass spectrometry.
Topics: Biomarkers; Case-Control Studies; Chromatography, Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Humans; Linear Models; Male; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Sex Characteristics; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2008 |
Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients: response to Stettler et al.
Topics: Albuminuria; Blood Glucose; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Humans; Multivariate Analysis; Postprandial Period | 2008 |
1,5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes.
Topics: Adult; Aged; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Linear Models; Male; Middle Aged; Prediabetic State; Young Adult | 2009 |
Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes.
Topics: Adult; Aged; Aged, 80 and over; Asian People; Black People; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Ethnicity; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Racial Groups; White People | 2009 |
[Practice guidelines for treatment of diabetes mellitus and indicator of the blood glucose control--new standardization of HbA1c].
Topics: Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; International System of Units; Practice Guidelines as Topic; Reference Standards; Serum Albumin | 2009 |
Screening for type 2 diabetes in obese youth.
Topics: Adolescent; Age Factors; Blood Glucose; Body Mass Index; Child; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperglycemia; Insulin; Insulin Resistance; Male; Mass Screening; Obesity; Predictive Value of Tests; ROC Curve; Texas | 2009 |
Close relationship between serum concentrations of 1,5-anhydroglucitol and uric acid in non-diabetic male subjects implies common renal transport system.
Topics: Adult; Biological Transport; Blood Glucose; Deoxyglucose; Glucose Tolerance Test; Humans; Kidney Tubules; Male; Metabolism; Middle Aged; Uric Acid | 2009 |
Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM).
Topics: Aged; Area Under Curve; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Complications; Diabetes Mellitus; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Monitoring, Ambulatory; Regression Analysis; Serum Albumin | 2010 |
Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes.
Topics: Adolescent; Adult; Age of Onset; Blood Glucose; Body Mass Index; Child; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Glucokinase; Glucose Tolerance Test; Glycated Hemoglobin; Hepatocyte Nuclear Factor 1-alpha; Humans; Insulin-Secreting Cells; Mutation; Prognosis; ROC Curve; Young Adult | 2010 |
Determining glycemic control.
Topics: Biomarkers; Deoxyglucose; Diabetes Mellitus; Humans; Postprandial Period; Predictive Value of Tests; Reagent Kits, Diagnostic | 2009 |
Habitual intake of dairy products influences serum 1,5-anhydroglucitol levels independently of plasma glucose.
Topics: Biomarkers; Blood Glucose; Dairy Products; Deoxyglucose; Diet; Feeding Behavior; Female; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Serum Albumin; Surveys and Questionnaires | 2010 |
Improvement of postprandial hyperglycemia and arterial stiffness upon switching from premixed human insulin 30/70 to biphasic insulin aspart 30/70.
Topics: Aged; Arteries; Biphasic Insulins; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Aspart; Insulin, Isophane; Male; Middle Aged | 2011 |
Serum 1,5-anhydroglucitol levels in patients with fulminant type 1 diabetes are lower than those in patients with type 2 diabetes.
Topics: Adult; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Middle Aged | 2010 |
1,5-Anhydroglucitol levels are low irrespective of plasma glucose levels in patients with chronic liver disease.
Topics: Blood Glucose; Case-Control Studies; Chronic Disease; Deoxyglucose; Diabetes Complications; Female; Humans; Liver Diseases; Male; Middle Aged; Multivariate Analysis; Regression Analysis | 2011 |
Correlation between baseline serum 1,5-anhydroglucitol levels and 2-hour post-challenge glucose levels during oral glucose tolerance tests.
Topics: Adult; Blood Glucose; Deoxyglucose; Glucose Tolerance Test; Humans; Hyperglycemia; Male; Middle Aged; ROC Curve; Sensitivity and Specificity | 2011 |
Comparison of two assays for serum 1,5-anhydroglucitol.
Topics: Blood Chemical Analysis; Blood Specimen Collection; Deoxyglucose; Female; Humans; Male; Middle Aged | 2011 |
Racial differences in glycemic markers: a cross-sectional analysis of community-based data.
Topics: Aged; Black People; Blood Glucose; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus; Erythrocytes; Female; Fructosamine; Glycated Hemoglobin; Humans; Male; White People | 2011 |
Serum 1,5-anhydro-D-glucitol levels predict first-ever cardiovascular disease: an 11-year population-based cohort study in Japan, the Suita study.
Topics: Adult; Aged; Body Mass Index; Cardiovascular Diseases; Cohort Studies; Coronary Disease; Deoxyglucose; Female; Humans; Japan; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk; Stroke; Treatment Outcome | 2011 |
The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring.
Topics: Adolescent; Blood Glucose; Blood Glucose Self-Monitoring; Child; Child, Preschool; Deoxyglucose; Diabetes Mellitus, Type 1; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Serum Albumin | 2011 |
Evaluation of serum and urine 1,5-anhydro-D-glucitol and myo-inositol concentrations in healthy dogs.
Topics: Animals; Blood Glucose; Deoxyglucose; Diabetes Mellitus; Dog Diseases; Dogs; Female; Inositol; Insulin; Male; Pancreas, Artificial | 2011 |
Pycnalin, a new α-glucosidase inhibitor from Acer pycnanthum.
Topics: Acer; Biphenyl Compounds; Deoxyglucose; Enzyme Inhibitors; Free Radical Scavengers; Gallic Acid; Glycoside Hydrolase Inhibitors; Glycosides; Humans; Hypoglycemia; Hypoglycemic Agents; Magnetic Resonance Spectroscopy; Picrates; Plant Extracts; Sorbitol | 2011 |
Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Monitoring, Physiologic | 2013 |
The quest for the perfect biomarker of long-term glycemia: new studies, new trials and tribulations.
Topics: Animals; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Complications; Diabetes Mellitus; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemia; Predictive Value of Tests; Serum Albumin | 2011 |
Plasma 1,5 anhydroglucitol levels, a measure of short-term glycaemia: assay assessment and lower levels in diabetic vs. non-diabetic subjects.
Topics: Adult; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Middle Aged | 2012 |
Evaluation of 1,5-anhydroglucitol, hemoglobin A1c, and glucose levels in youth and young adults with type 1 diabetes and healthy controls.
Topics: Adolescent; Adult; Blood Glucose; Child; Cohort Studies; Deoxyglucose; Diabetes Mellitus, Type 1; Female; Glycated Hemoglobin; Humans; Male | 2012 |
Serum 1,5-anhydroglucitol is low in gastrectomized men.
Topics: Deoxyglucose; Diabetes Mellitus; Gastrectomy; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Male; Middle Aged; Regression Analysis | 2014 |
A pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markers.
Topics: 1-Deoxynojirimycin; Aged; Biomarkers; Blood Glucose; Case-Control Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Incretins; Insulin; Male; Middle Aged; Monitoring, Physiologic; Pilot Projects; Postprandial Period; Pyrazines; Sitagliptin Phosphate; Triazoles | 2011 |
Serum 1,5-anhydroglucitol concentrations are a reliable index of glycemic control in type 2 diabetes with mild or moderate renal dysfunction.
Topics: Blood Glucose; Chronic Disease; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Glomerular Filtration Rate; Humans; Kidney Diseases | 2012 |
A study on the association of serum 1,5-anhydroglucitol levels and the hyperglycaemic excursions as measured by continuous glucose monitoring system among people with type 2 diabetes in China.
Topics: Adult; Aged; Area Under Curve; Blood Glucose; Blood Glucose Self-Monitoring; China; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Young Adult | 2012 |
The lack of long-range negative correlations in glucose dynamics is associated with worse glucose control in patients with diabetes mellitus.
Topics: Adult; Blood Glucose; C-Peptide; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Serum Albumin | 2012 |
Serum 1,5-anhydroglucitol is associated with diabetic retinopathy in Type 2 diabetes.
Topics: Albuminuria; Biomarkers; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Logistic Models; Male; Middle Aged; Prevalence; Republic of Korea; Risk Factors | 2012 |
Correlation between 1,5-anhydroglucitol and glycemic excursions in type 2 diabetic patients.
Topics: Aged; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Postprandial Period | 2011 |
Potential for use of 1,5-anhydroglucitol when initiating insulin therapy in people with type 2 diabetes and suboptimal control with oral antidiabetic drugs.
Topics: Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin Glargine; Insulin Lispro; Insulin, Long-Acting; Male; Middle Aged; Treatment Outcome; Weight Gain | 2012 |
Effects of sex and age on serum 1,5-anhydroglucitol in nondiabetic subjects.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Blood Glucose; Creatinine; Deoxyglucose; Female; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Male; Middle Aged; Regression Analysis; Sex Factors; Young Adult | 2012 |
Increased 1,5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Fructosamine; Glucose Tolerance Test; Homeostasis; Humans; Hypoglycemic Agents; Insulin; Logistic Models; Longitudinal Studies; Male; Middle Aged; Odds Ratio; Predictive Value of Tests; Remission Induction; Time Factors | 2012 |
Clinical and forensic examinations of glycemic marker 1,5-anhydroglucitol by means of high performance liquid chromatography tandem mass spectrometry.
Topics: Biomarkers; Chromatography, Liquid; Deoxyglucose; Diabetes Mellitus; Diabetic Coma; Forensic Pathology; Humans; Hyperglycemia; Tandem Mass Spectrometry | 2012 |
Alternative markers of hyperglycemia and risk of diabetes.
Topics: Aged; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Male; Proportional Hazards Models; Risk Factors; Serum Albumin | 2012 |
Predicting outcomes and assessing control with alternate glycemic markers.
Topics: Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Humans; Hypoglycemic Agents; Insulin; Male | 2012 |
Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose.
Topics: Age Factors; Aged; Biomarkers; Blood Glucose; Coronary Disease; Cross-Sectional Studies; Deoxyglucose; Fasting; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Glycosylation; Humans; Hyperglycemia; Hypertension; Male; Renal Insufficiency, Chronic; Serum Albumin; Sex Factors | 2012 |
Protective effects of dietary 1,5-anhydro-D-glucitol as a blood glucose regulator in diabetes and metabolic syndrome.
Topics: Administration, Oral; alpha-Glucosidases; Animals; Blood Glucose; Cholesterol; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Glycoside Hydrolase Inhibitors; Glycosuria; Hyperglycemia; Intestines; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL | 2013 |
1,5-Anhydroglucitol as a marker of maternal glycaemic control and predictor of neonatal birthweight in pregnancies complicated by type 1 diabetes mellitus.
Topics: Adult; Birth Weight; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 1; Female; Glucose; Glycated Hemoglobin; Humans; Infant, Newborn; Maternal Age; Pregnancy; Pregnancy in Diabetics; Pregnancy Trimester, Third; Regression Analysis; ROC Curve | 2013 |
Relationship between postprandial glucose level and carotid artery stiffness in patients without diabetes or cardiovascular disease.
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Carotid Arteries; Carotid Artery Diseases; Carotid Intima-Media Thickness; Deoxyglucose; Female; Humans; Hyperglycemia; Linear Models; Male; Middle Aged; Multivariate Analysis; Postprandial Period; Predictive Value of Tests; Pulse Wave Analysis; Risk Factors; Vascular Stiffness | 2013 |
Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Area Under Curve; Biomarkers; Blood Glucose; Blood Glucose Self-Monitoring; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans; Hyperglycemia; Male; Mass Screening; Middle Aged; Predictive Value of Tests; Republic of Korea | 2013 |
Serum uric acid in relation to serum 1,5-anhydroglucitol levels in patients with and without type 2 diabetes mellitus.
Topics: Aged; Aged, 80 and over; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Male; Middle Aged; Outpatients; Regression Analysis; Uric Acid | 2013 |
The use of 1.5-anhydroglucitol for monitoring glycemic control in islet transplant recipients.
Topics: Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 1; Female; Glycated Hemoglobin; Humans; Islets of Langerhans Transplantation; Male; Middle Aged; Postprandial Period; Retrospective Studies; Transplant Recipients | 2014 |
Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease.
Topics: Adult; Aged; Blood Glucose; Deoxyglucose; Disease Progression; Fatty Liver; Female; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Non-alcoholic Fatty Liver Disease; Prognosis | 2013 |
Change in urinary N-acetyl-β-d-glucosaminidase levels relevant to postprandial glycemic control conditions in subjects without diabetes mellitus.
Topics: Acetylglucosaminidase; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Creatinine; Deoxyglucose; Female; Humans; Male; Middle Aged; Postprandial Period; Young Adult | 2014 |
1,5-Anhydroglucitol in saliva is a noninvasive marker of short-term glycemic control.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Case-Control Studies; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Humans; Male; Mass Spectrometry; Metabolomics; Middle Aged; Saliva; Young Adult | 2014 |
1,5 Anhydroglucitol serum concentration as a biomarker for screening gestational diabetes in early pregnancy.
Topics: Biomarkers; Deoxyglucose; Diabetes, Gestational; Early Diagnosis; Female; Humans; Mass Screening; Pregnancy | 2014 |
1,5-Anhydro-D-glucitol predicts coronary artery disease prevalence and complexity.
Topics: Aged; Biomarkers; Coronary Artery Disease; Deoxyglucose; Female; Glycated Hemoglobin; Humans; Male; Predictive Value of Tests; Regression Analysis; Sensitivity and Specificity | 2014 |
Lower 1,5-anhydroglucitol is associated with denovo coronary artery disease in patients at high cardiovascular risk.
Topics: Aged; Biomarkers; Blood Glucose; Coronary Angiography; Coronary Artery Disease; Deoxyglucose; Diabetes Mellitus; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Factors; ROC Curve; Serum Albumin | 2015 |
Serum metabolomic profiling and incident CKD among African Americans.
Topics: Biomarkers; Black or African American; Chromatography, Liquid; Creatine; Cross-Sectional Studies; Deoxyglucose; Female; Gas Chromatography-Mass Spectrometry; Humans; Incidence; Indican; Kidney; Linear Models; Longitudinal Studies; Male; Metabolomics; Middle Aged; Proportional Hazards Models; Pyrrolidonecarboxylic Acid; Renal Insufficiency, Chronic; Risk Factors; Time Factors; United States | 2014 |
Add-on treatment with teneligliptin ameliorates glucose fluctuations and improves glycemic control index in Japanese patients with type 2 diabetes on insulin therapy.
Topics: Aged; C-Reactive Protein; Combined Modality Therapy; Deoxyglucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Dipeptidyl-Peptidase IV Inhibitors; Drug Resistance; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Insulin; Japan; Male; Middle Aged; Monitoring, Ambulatory; Pilot Projects; Prospective Studies; Pyrazoles; Serum Albumin; Thiazolidines | 2014 |
Association of 1,5-anhydroglucitol with diabetes and microvascular conditions.
Topics: Cohort Studies; Deoxyglucose; Diabetes Mellitus; Diabetic Retinopathy; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Renal Insufficiency, Chronic; ROC Curve | 2014 |
Moving beyond mean glycemia: 1,5-anhydroglucitol and microvascular complications of diabetes.
Topics: Deoxyglucose; Diabetes Mellitus; Diabetic Retinopathy; Female; Humans; Hyperglycemia; Male; Renal Insufficiency, Chronic | 2014 |
In vitro immunocompetence of two compounds isolated from Polygala tenuifolia and development of resistance against grass carp reovirus (GCRV) and Dactylogyrus intermedius in respective host.
Topics: Animals; Carps; Cell Survival; Cells, Cultured; Cinnamates; Deoxyglucose; Gene Expression Regulation; In Vitro Techniques; Methanol; Plant Extracts; Platyhelminths; Polygala; Reoviridae | 2014 |
Reactivity of sorbose dehydrogenase from Sinorhizobium sp. 97507 for 1,5-anhydro-D-glucitol.
Topics: Bacterial Proteins; Carbohydrate Dehydrogenases; Deoxyglucose; Recombinant Proteins; Sinorhizobium; Sorbose; Substrate Specificity | 2015 |
1,5-anhydroglucitol is associated with early-phase insulin secretion in chinese patients with newly diagnosed type 2 diabetes mellitus.
Topics: Adult; Aged; Asian People; China; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Homeostasis; Humans; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Middle Aged; Serum Albumin | 2015 |
1,5-ANHYDROGLUCITOL AND NEONATAL COMPLICATIONS IN PREGNANCY COMPLICATED BY DIABETES.
Topics: Adult; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Humans; Hypoglycemia; Infant, Newborn; Infant, Newborn, Diseases; Male; Pregnancy; Pregnancy Complications | 2015 |
Association of cerebral white matter lesions with cognitive function and mood in Japanese elderly people: a population-based study.
Topics: Affect; Aged; Aged, 80 and over; Alcohol Drinking; Brain Diseases; Cognition; Comorbidity; Deoxyglucose; Depression; Female; Geriatric Assessment; Humans; Hypertension; Intelligence Tests; Japan; Life Style; Magnetic Resonance Imaging; Male; Motor Skills; Neuropsychological Tests; Risk Factors; Severity of Illness Index; White Matter | 2015 |
Glycated albumin is more closely correlated with coronary artery disease than 1,5-anhydroglucitol and glycated hemoglobin A1c.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Coronary Artery Disease; Cross-Sectional Studies; Deoxyglucose; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Serum Albumin | 2015 |
1,5-Anhydroglucitol: a new predictor of neonatal birth weight in diabetic pregnancies.
Topics: Biomarkers; Birth Weight; Cohort Studies; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Gestational Age; Glycated Hemoglobin; Humans; Infant, Newborn; Male; Pregnancy; Pregnancy in Diabetics; Retrospective Studies | 2015 |
Lower 1,5-anhydroglucitol is associated with adverse clinical events after percutaneous coronary intervention.
Topics: Aged; Biomarkers; Blood Glucose; Chi-Square Distribution; Coronary Angiography; Deoxyglucose; Diabetes Mellitus; Down-Regulation; Female; Glycated Hemoglobin; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2016 |
NMR-Based Metabolomic Study on Isatis tinctoria: Comparison of Different Accessions, Harvesting Dates, and the Effect of Repeated Harvesting.
Topics: Deoxyglucose; Fatty Acids, Unsaturated; Flavonoids; Isatis; Magnetic Resonance Spectroscopy; Metabolomics; Molecular Structure; Plant Leaves; Plants, Medicinal; Porphyrins; Sucrose; Terpenes | 2015 |
HOMA-IR Values are Associated With Glycemic Control in Japanese Subjects Without Diabetes or Obesity: The KOBE Study.
Topics: Aged; Biomarkers; Blood Glucose; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus; Fasting; Female; Glycated Hemoglobin; Homeostasis; Humans; Insulin Resistance; Japan; Male; Middle Aged; Models, Biological; Obesity | 2015 |
Association of hemoglobin A1c and glycated albumin with carotid atherosclerosis in community-dwelling Japanese subjects: the Hisayama Study.
Topics: Adult; Aged; Atherosclerosis; Biomarkers; Blood Glucose; Blood Pressure; Carotid Artery Diseases; Carotid Intima-Media Thickness; Cohort Studies; Cross-Sectional Studies; Deoxyglucose; Female; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Independent Living; Insulin Resistance; Japan; Male; Middle Aged; Prospective Studies; Serum Albumin; Statistics as Topic | 2015 |
Low levels of C-peptide have clinical significance for established Type 1 diabetes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose; C-Peptide; Child; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 1; Glycated Hemoglobin; Humans; Middle Aged; Prognosis; Young Adult | 2015 |
Teneligliptin improves left ventricular diastolic function and endothelial function in patients with diabetes.
Topics: Adiponectin; Aged; Deoxyglucose; Diabetes Mellitus, Type 2; Diastole; Dipeptidyl-Peptidase IV Inhibitors; Echocardiography; Endothelium, Vascular; Female; Glycated Hemoglobin; Humans; Japan; Linear Models; Male; Middle Aged; Pyrazoles; Thiazolidines; Ventricular Function, Left | 2016 |
Effect of postprandial hyperglycaemia on coronary flow reserve in patients with impaired glucose tolerance and type 2 diabetes mellitus.
Topics: Aged; Aged, 80 and over; Coronary Circulation; Coronary Vessels; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose; Glucose Intolerance; Humans; Hyperglycemia; Male; Middle Aged | 2015 |
Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality.
Topics: Aged; Cardiovascular Diseases; Coronary Disease; Deoxyglucose; Diabetes Mellitus; Female; Glycated Hemoglobin; Heart Failure; Humans; Incidence; Longitudinal Studies; Male; Middle Aged; Mortality; Proportional Hazards Models; Prospective Studies; Stroke; United States | 2016 |
Measurement of Postmortem 1,5-anhydroglucitol in Vitreous Humor for Forensic Diagnosis.
Topics: Autopsy; Blood Glucose; Deoxyglucose; Humans; Postmortem Changes; Vitreous Body | 2016 |
Total Short-term Variability in Biomarkers of Hyperglycemia in Older Adults.
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Cohort Studies; Deoxyglucose; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Male; Reproducibility of Results; Sensitivity and Specificity; Serum Albumin | 2015 |
Ability of 1,5-Anhydro-d-glucitol Values to Predict Coronary Artery Disease in a Non-Diabetic Population.
Topics: Aged; Biomarkers; Blood Glucose; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Deoxyglucose; Early Diagnosis; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Japan; Male; Middle Aged; Predictive Value of Tests; Risk Assessment; Risk Factors | 2015 |
Model analysis of effect of canagliflozin (Invokana), a sodium-glucose cotransporter 2 inhibitor, to alter plasma 1,5-anhydroglucitol.
Topics: Canagliflozin; Deoxyglucose; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Models, Biological; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2016 |
Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: A comparative study with HbA1c and glycated albumin.
Topics: Aged; Albuminuria; Alpha-Globulins; Biomarkers; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Regression Analysis; Renal Insufficiency, Chronic; Serum Albumin; Severity of Illness Index | 2016 |
Racial Differences in and Prognostic Value of Biomarkers of Hyperglycemia.
Topics: Biomarkers; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Deoxyglucose; Diabetes Mellitus; Female; Follow-Up Studies; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Prognosis; Proportional Hazards Models; Prospective Studies; Racial Groups; Risk Factors; Serum Albumin | 2016 |
Short Note: Low Levels of Serum 1,5-Anhydroglucitol during Pregnancy Compared to Blood Glucose Measured by Continuous Glucose Monitoring.
Topics: Adult; Blood Glucose; Blood Glucose Self-Monitoring; Deoxyglucose; Female; Glycated Hemoglobin; Humans; Pregnancy | 2016 |
Measurement of 1,5-anhydroglucitol in blood and saliva: from non-targeted metabolomics to biochemical assay.
Topics: Adult; Aged; Biological Assay; Deoxyglucose; Female; Galactose; Humans; Male; Mass Spectrometry; Metabolome; Metabolomics; Middle Aged; Osmolar Concentration; Saliva | 2016 |
The association of serum glycated albumin with the prevalence of diabetic retinopathy in Korean patients with type 2 diabetes mellitus.
Topics: Biomarkers; Blood Glucose; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Republic of Korea; Serum Albumin | 2016 |
Novel insights into development of diabetic bladder disorder provided by metabolomic analysis of the rat nondiabetic and diabetic detrusor and urothelial layer.
Topics: Amino Acids, Branched-Chain; Animals; Bile Acids and Salts; Case-Control Studies; Citric Acid Cycle; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucose; Glycation End Products, Advanced; Glycolysis; Hydroxybutyrates; Lactic Acid; Lipid Metabolism; Male; Metabolomics; Muscle, Smooth; Oxidation-Reduction; Oxidative Stress; Pentose Phosphate Pathway; Polymers; Prostaglandins; Rats; Rats, Inbred F344; Sorbitol; Urinary Bladder; Urinary Bladder Diseases; Urothelium | 2016 |
Association of CD34/CD133/VEGFR2-Positive Cell Numbers with Eicosapentaenoic Acid and Postprandial Hyperglycemia in Patients with Coronary Artery Disease.
Topics: AC133 Antigen; Aged; Antigens, CD34; Cell Count; Coronary Artery Disease; Deoxyglucose; Diabetes Mellitus, Type 2; Eicosapentaenoic Acid; Endothelium, Vascular; Female; Humans; Hyperglycemia; Male; Middle Aged; Neovascularization, Pathologic; Risk Factors; Stem Cells; Vascular Endothelial Growth Factor Receptor-2 | 2016 |
Association of a Biomarker of Glucose Peaks, 1,5-Anhydroglucitol, With Subclinical Cardiovascular Disease.
Topics: Adult; Aged; Atherosclerosis; Biomarkers; Blood Glucose; Cardiovascular Diseases; Carotid Intima-Media Thickness; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus; Female; Humans; Logistic Models; Male; Middle Aged; Plaque, Atherosclerotic; Risk Factors; Sensitivity and Specificity; Troponin T; Young Adult | 2016 |
Impact of serum 1,5-anhydro-d-glucitol level on prediction of major adverse cardiac and cerebrovascular events in non-diabetic patients without coronary artery disease.
Topics: Aged; Area Under Curve; Blood Glucose; Cerebrovascular Disorders; Colorimetry; Coronary Angiography; Coronary Artery Disease; Deoxyglucose; Female; Follow-Up Studies; Heart Diseases; Humans; Hyperglycemia; Kaplan-Meier Estimate; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models | 2016 |
Alcohol consumption reduces HbA1c and glycated albumin concentrations but not 1,5-anhydroglucitol.
Topics: Alcohol Drinking; Blood Glucose; Deoxyglucose; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Serum Albumin | 2017 |
Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention.
Topics: Aged; Biomarkers; Blood Glucose; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Deoxyglucose; Fasting; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Male; Middle Aged; Percutaneous Coronary Intervention; Predictive Value of Tests; Retreatment; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2016 |
The establishment of biological reference intervals of nontraditional glycemic markers in a Chinese population.
Topics: Adult; Aged; Asian People; Biomarkers; Blood Chemical Analysis; Blood Glucose; Deoxyglucose; Female; Fructosamine; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Reference Values; Serum Albumin; Young Adult | 2017 |
Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
Topics: Adolescent; Area Under Curve; Biomarkers; Blood Glucose; Child; Cohort Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Male; Monitoring, Ambulatory; Prediabetic State; Reproducibility of Results; Serum Albumin | 2017 |
Serum 1,5-anhydroglucitol level as a screening tool for diabetes mellitus in a community-based population at high risk of diabetes.
Topics: Adult; Aged; Biomarkers; Blood Glucose; China; Deoxyglucose; Diabetes Mellitus; Female; Glucose Tolerance Test; Humans; Male; Middle Aged; Population Surveillance; Postprandial Period; Residence Characteristics; Risk Factors | 2017 |
Protein Modeling and Molecular Dynamics Simulation of Cloned Regucalcin (RGN) Gene from Bubalus bubalis.
Topics: Animals; Binding Sites; Buffaloes; Calcium-Binding Proteins; Deoxyglucose; Male; Models, Molecular; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Binding; Testis | 2017 |
Serum 1,5-anhydroglucitol levels slightly increase rather than decrease after a glucose load in subjects with different glucose tolerance status.
Topics: Adult; Aged; Blood Glucose; Deoxyglucose; Diabetes Mellitus; Fasting; Female; Glucose; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Male; Middle Aged | 2017 |
Excretion rates of 1,5-anhydro-D-glucitol, uric acid and microalbuminuria as glycemic control indexes in patients with type 2 diabetes.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Retrospective Studies; ROC Curve; Uric Acid; Young Adult | 2017 |
Global and targeted metabolomics of synovial fluid discovers special osteoarthritis metabolites.
Topics: Arthritis, Rheumatoid; Case-Control Studies; Deoxyglucose; Female; Gluconates; Glutamine; Humans; Lactones; Male; Metabolome; Metabolomics; Middle Aged; Osteoarthritis, Knee; Synovial Fluid | 2017 |
Serum Levels of 1,5-Anhydroglucitol and Risk of Incident End-Stage Renal Disease.
Topics: Biomarkers; Blood Glucose; Cohort Studies; Deoxyglucose; Diabetes Complications; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Hyperglycemia; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Regression Analysis; Risk Factors; Surveys and Questionnaires | 2017 |
Genome-wide association study of 1,5-anhydroglucitol identifies novel genetic loci linked to glucose metabolism.
Topics: Aged; Black or African American; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Glucose; Glycated Hemoglobin; Humans; Hyperglycemia; Insulin; Male; Middle Aged; Minichromosome Maintenance Complex Component 6; Sodium-Glucose Transporter 1; White People | 2017 |
A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus.
Topics: Adult; Aged; Benzhydryl Compounds; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucokinase; Glucosides; Glycosuria; Hepatocyte Nuclear Factor 1-alpha; Humans; Hypoglycemic Agents; Male; Middle Aged; Mutation; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Young Adult | 2017 |
Alternative Measures of Hyperglycemia and Risk of Alzheimer's Disease in the Community: The Hisayama Study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Deoxyglucose; Female; Follow-Up Studies; Glucose Intolerance; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Incidence; Independent Living; Japan; Male; Multivariate Analysis; Proportional Hazards Models; Prospective Studies; Risk Factors; Serum Albumin | 2017 |
Effects of 1,5-anhydroglucitol on postprandial blood glucose and insulin levels and hydrogen excretion in rats and healthy humans.
Topics: Adult; alpha-Glucosidases; Animals; Blood Glucose; Deoxyglucose; Disaccharidases; Enzyme Inhibitors; Female; Glucose; Glycoside Hydrolase Inhibitors; Humans; Hydrogen; Insulin; Intestinal Absorption; Intestine, Small; Male; Postprandial Period; Rats; Rats, Wistar; Sucrase; Sucrose | 2017 |
A computational model of 1,5-AG dynamics during pregnancy.
Topics: Computer Simulation; Deoxyglucose; Diabetes, Gestational; Female; Hemodynamics; Humans; Models, Theoretical; Pregnancy; Pregnancy in Diabetics | 2017 |
Serum 1,5-anhydroglucitol when used with fasting plasma glucose improves the efficiency of diabetes screening in a Chinese population.
Topics: Adult; Asian People; Blood Glucose; Deoxyglucose; Diabetes Mellitus; Diagnostic Tests, Routine; Fasting; Female; Humans; Male; Mass Screening; Middle Aged; Sensitivity and Specificity; Serum | 2017 |
Metabolomic Alterations Associated with Cause of CKD.
Topics: Adult; Citrulline; Deoxyglucose; Female; Glomerulonephritis; Guanosine; Hippurates; Homovanillic Acid; Humans; Kynurenic Acid; Male; Metabolome; Middle Aged; Palmitic Acids; Polycystic Kidney Diseases; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic | 2017 |
A decrease in serum 1,5-anhydroglucitol levels is associated with the presence of a first-degree family history of diabetes in a Chinese population with normal glucose tolerance.
Topics: Adult; Aged; Asian People; China; Chromatography, High Pressure Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Family; Female; Glucose Tolerance Test; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Logistic Models; Male; Middle Aged; Serum Albumin; Young Adult | 2018 |
Serum 1,5-Anhydroglucitol: Risk Factor of Acute Ischemic Stroke and Transient Ischemic Attack in Well-Controlled Diabetes.
Topics: Aged; Aged, 80 and over; Biomarkers; Brain Ischemia; Deoxyglucose; Diabetes Mellitus; Down-Regulation; Electronic Health Records; Female; Glycated Hemoglobin; Humans; Ischemic Attack, Transient; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Stroke; Time Factors | 2017 |
Low 1,5-anhydroglucitol levels are associated with long-term cardiac mortality in acute coronary syndrome patients with hemoglobin A1c levels less than 7.0.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Cause of Death; Chi-Square Distribution; Coronary Angiography; Deoxyglucose; Disease-Free Survival; Down-Regulation; Female; Glycated Hemoglobin; Hospitals, University; Humans; Hyperglycemia; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Postprandial Period; Proportional Hazards Models; Retrospective Studies; Risk Factors; Time Factors | 2017 |
Serum 1,5-Anhydroglucitol Concentrations Remain Valid as a Glycemic Control Marker In Diabetes with Earlier Chronic Kidney Disease Stages.
Topics: Adult; Aged; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Renal Insufficiency, Chronic; Uric Acid | 2019 |
The metabolism and transport of 1,5-anhydroglucitol in cells.
Topics: Animals; Biological Transport; Cells, Cultured; Deoxyglucose; Glucose; Glucose Oxidase; Hep G2 Cells; Hepatocytes; Hexokinase; Humans; Intracellular Fluid; Male; Mice; Mice, Inbred C57BL | 2018 |
First trimester serum biomarkers to predict gestational diabetes in a high-risk cohort: Striving for clinically useful thresholds.
Topics: Adiponectin; Adult; Biomarkers; C-Reactive Protein; Cohort Studies; Deoxyglucose; Diabetes, Gestational; Down-Regulation; Early Diagnosis; Female; Glucose Tolerance Test; Humans; Incidence; Ireland; Maternal Serum Screening Tests; Pregnancy; Pregnancy Trimesters; Risk Factors; Sensitivity and Specificity; Sex Hormone-Binding Globulin | 2018 |
Establishment of Community-Based Reference Intervals for Fructosamine, Glycated Albumin, and 1,5-Anhydroglucitol.
Topics: Deoxyglucose; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Reference Standards; Serum Albumin | 2018 |
Colorimetric detection of 1,5-anhydroglucitol based on graphene quantum dots and enzyme-catalyzed reaction.
Topics: Biocatalysis; Colorimetry; Deoxyglucose; Graphite; Humans; Hydrogen Peroxide; Oxidation-Reduction; Peroxidase; Quantum Dots; Solutions; Spectrophotometry, Ultraviolet | 2018 |
Metabolome analysis for pancreatic cancer risk in nested case-control study: Japan Public Health Center-based prospective Study.
Topics: Adult; Aged; Asparagine; Case-Control Studies; Deoxyglucose; Female; Humans; Logistic Models; Male; Metabolome; Methionine; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Risk | 2018 |
Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.
Topics: Biomarkers; Blood Glucose; Critical Illness; Deoxyglucose; Diabetes Mellitus; Diabetic Foot; Disease Progression; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Incidence; Ischemia; Lower Extremity; Male; Middle Aged; Peripheral Arterial Disease; Predictive Value of Tests; Prevalence; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Serum Albumin; Severity of Illness Index; Time Factors; United States | 2018 |
1,5-Anhydro-d-glucitol in vitreous humor and cerebrospinal fluid - A helpful tool for identification of diabetes and diabetic coma post mortem.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Chromatography, Liquid; Deoxyglucose; Diabetic Coma; Female; Glucose; Glycated Hemoglobin; Humans; Hyperglycemia; Linear Models; Male; Mass Spectrometry; Middle Aged; Postmortem Changes; Vitreous Body; Young Adult | 2018 |
Reference intervals for serum 1,5-anhydroglucitol in children, adolescents, adults, and pregnant women.
Topics: Adolescent; Adult; Biomarkers; Child; Child, Preschool; Deoxyglucose; Female; Humans; Infant; Infant, Newborn; Male; Pregnancy; Young Adult | 2018 |
Diagnostic Performance of 1,5-Anhydroglucitol Compared to 2-H Glucose in the Atherosclerosis Risk in Communities Study.
Topics: Aged; Atherosclerosis; Blood Glucose; Cross-Sectional Studies; Deoxyglucose; Female; Humans; Hyperglycemia; Male; Mass Screening; Middle Aged; Risk Factors; ROC Curve; Sensitivity and Specificity | 2018 |
1,5 Anhydroglucitol in gestational diabetes mellitus.
Topics: Adult; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes, Gestational; Female; Glucose Tolerance Test; Glycated Hemoglobin; Humans; India; Odds Ratio; Pregnancy; ROC Curve | 2019 |
A decision algorithm to identify patients with high probability of monogenic diabetes due to HNF1A mutations.
Topics: Adult; Aged; Algorithms; Biomarkers; C-Reactive Protein; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucokinase; Hepatocyte Nuclear Factor 1-alpha; Humans; Male; Middle Aged; Young Adult | 2019 |
Salivary 1,5-Anhydroglucitol and Vitamin Levels in Relation to Caries Risk in Children.
Topics: Adolescent; Ascorbic Acid; Child; Dental Caries; Deoxyglucose; Female; Humans; Male; Risk Factors; Saliva; Vitamin A; Vitamin E | 2019 |
Rare variants in SLC5A10 are associated with serum 1,5-anhydroglucitol (1,5-AG) in the Atherosclerosis Risk in Communities (ARIC) Study.
Topics: Atherosclerosis; Deoxyglucose; Exome Sequencing; Female; Humans; Longitudinal Studies; Male; Middle Aged; Polymorphism, Single Nucleotide; Risk Factors; Sodium-Glucose Transport Proteins | 2019 |
Hyperglycemia and Carotenoid Intake Are Associated with Serum Carotenoids in Youth with Type 1 Diabetes.
Topics: Adolescent; Biomarkers; Boston; Carotenoids; Child; Deoxyglucose; Diabetes Mellitus, Type 1; Diet Records; Dinoprost; Female; Fruit; Glycated Hemoglobin; Humans; Hyperglycemia; Male; Oxidative Stress; Regression Analysis; Vegetables | 2019 |
Impact of serum 1,5-anhydro-D-glucitol level on the prediction of severe coronary artery calcification: an intravascular ultrasound study.
Topics: Biomarkers; Blood Glucose; Coronary Artery Disease; Coronary Vessels; Deoxyglucose; Down-Regulation; Female; Humans; Hyperglycemia; Male; Middle Aged; Plaque, Atherosclerotic; Postprandial Period; Predictive Value of Tests; Prospective Studies; Severity of Illness Index; Ultrasonography, Interventional; Vascular Calcification | 2019 |
Hemolysis causes a decrease in HbA1c level but not in glycated albumin or 1,5-anhydroglucitol level.
Topics: Adult; Aged; Deoxyglucose; Diabetes Complications; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Hemolysis; Humans; Middle Aged; Serum Albumin | 2019 |
Inverse association between 1,5-anhydroglucitol and neonatal diabetic complications.
Topics: Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Fructosamine; Glycated Hemoglobin; Humans; Infant, Newborn; Infant, Newborn, Diseases; Pregnancy; Pregnancy in Diabetics; Prospective Studies; Risk Factors | 2019 |
Screening for cystic fibrosis-related diabetes and prediabetes: Evaluating 1,5-anhydroglucitol, fructosamine, glycated albumin, and hemoglobin A1c.
Topics: Adolescent; Child; Cystic Fibrosis; Deoxyglucose; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Mass Screening; Prediabetic State; Serum Albumin | 2019 |
Serum 1,5-Anhydroglucitol Concentration as a Biomarker for Type 1 Diabetes in Adults and Children.
Topics: Adolescent; Adult; Biomarkers; Case-Control Studies; Child; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 1; Female; Humans; Male; Middle Aged; Risk Factors; ROC Curve; Young Adult | 2019 |
1,5-Anhydroglucitol × glycated hemoglobin A
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; China; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Islets of Langerhans; Male; Middle Aged; Young Adult | 2020 |
Development of an organ bath technique for isolated rat pancreas preparations to assess the effect of 1,5-AG on insulin secretion.
Topics: Animals; Deoxyglucose; Insulin Secretion; Pancreas; Rats; Tissue Culture Techniques | 2020 |
Synthesis and Comparative Structure-Activity Study of Carbohydrate-Based Phenolic Compounds as α-Glucosidase Inhibitors and Antioxidants.
Topics: alpha-Glucosidases; Antioxidants; Carbohydrates; Deoxyglucose; Gallic Acid; Glucosides; Glycoside Hydrolase Inhibitors; Molecular Structure; Plant Extracts; Polyphenols; Structure-Activity Relationship | 2019 |
Reference intervals for serum 1,5-anhydroglucitol of a population with normal glucose tolerance in Jiangsu Province.
Topics: Adult; Aged; Biomarkers; Blood Glucose; China; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Male; Middle Aged; Reference Values; Uric Acid; Young Adult | 2020 |
Diabetes Screening: Detection and Application of Saliva 1,5-Anhydroglucitol by Liquid Chromatography-Mass Spectrometry.
Topics: Adolescent; Adult; Aged; Biomarkers; Blood Glucose; China; Chromatography, Liquid; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Male; Mass Screening; Mass Spectrometry; Middle Aged; Prognosis; ROC Curve; Saliva; Young Adult | 2020 |
Serum 1,5-Anhydroglucitol to Glycated Albumin Ratio Can Help Early Distinguish Fulminant Type 1 Diabetes Mellitus from Newly Onset Type 1A Diabetes Mellitus.
Topics: Adult; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 1; Diagnosis, Differential; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Serum Albumin | 2020 |
Effect of 1,5-anhydroglucitol levels on culprit plaque rupture in diabetic patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Biomarkers; Blood Glucose; Coronary Artery Disease; Coronary Vessels; Deoxyglucose; Diabetes Mellitus, Type 2; Dinoprost; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Rupture, Spontaneous; Ultrasonography, Interventional | 2020 |
Differential Effects of Post-Weaning Diet and Maternal Obesity on Mouse Liver and Brain Metabolomes.
Topics: 3-Hydroxybutyric Acid; Animals; Anserine; Brain; Deoxyglucose; Diet; Energy Metabolism; Female; Homeostasis; Liver; Lysine; Male; Maternal Nutritional Physiological Phenomena; Maternal-Fetal Exchange; Metabolome; Mice, Inbred C57BL; Obesity, Maternal; Pregnancy; Prenatal Exposure Delayed Effects; Weaning | 2020 |
Associations of 1,5-Anhydroglucitol and 2-Hour Glucose with Major Clinical Outcomes in the Atherosclerosis Risk in Communities (ARIC) Study.
Topics: Atherosclerosis; Deoxyglucose; Glucose; Humans; Risk Factors | 2020 |
Paper-based 1,5-anhydroglucitol quantification using enzyme-based glucose elimination.
Topics: Deoxyglucose; Glucose; Glucose Oxidase; Humans; Sugars | 2020 |
Association between a biomarker of glucose spikes, 1,5-anhydroglucitol, and cancer mortality.
Topics: Biomarkers; Blood Glucose; Deoxyglucose; Female; Glucose; Humans; Male; Neoplasms | 2020 |
Association of time in range with hemoglobin A1c, glycated albumin and 1,5-anhydro-d-glucitol.
Topics: Adult; Aged; Blood Glucose Self-Monitoring; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucose Intolerance; Glucose Metabolism Disorders; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Glycemic Control; Humans; Male; Middle Aged; Retrospective Studies; Serum Albumin; Time Factors | 2021 |
[Research on consistency of different measurement methods for saliva 1,5-anhydroglucitol].
Topics: China; Deoxyglucose; Diabetes Mellitus; Female; Humans; Male; Saliva | 2020 |
Time-based investigation of urinary metabolic markers for Type 2 diabetes: Metabolomics approach for diabetes management.
Topics: Animals; Biomarkers; Carnitine; Cluster Analysis; Deoxyglucose; Diabetes Mellitus, Experimental; Disease Progression; Fructose; Fucose; Galactose; Glycosuria; Inositol; Magnetic Resonance Spectroscopy; Male; Metabolome; Metabolomics; Phenylalanine; Rats; Rats, Wistar; Streptozocin; Taurine; Time Factors | 2021 |
Human and mouse non-targeted metabolomics identify 1,5-anhydroglucitol as SGLT2-dependent glycemic marker.
Topics: Animals; Benzhydryl Compounds; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Double-Blind Method; Glucosides; Humans; Metabolome; Mice; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Combining serum 1,5-anhydroglucitol with fasting plasma glucose to detect diabetes mellitus in a community-based population with hypertension.
Topics: Blood Glucose; Deoxyglucose; Diabetes Mellitus; Fasting; Humans; Hypertension | 2021 |
Effects of 1,5-anhydro-D-glucitol on insulin secretion both in in vitro and ex vivo pancreatic preparations.
Topics: Animals; Deoxyglucose; Glucose; Insulin; Insulin Secretion; Pancreas; Rats; Sorbitol | 2022 |
Quantification of Glucose, fructose and 1,5-Anhydroglucitol in plasma of diabetic patients by ultra performance liquid chromatography tandem mass spectrometry.
Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Fructose; Glucose; Humans; Reproducibility of Results; Tandem Mass Spectrometry | 2022 |
Prognostic value of 1,5-anhydro-D-glucitol incorporating syntax score in acute coronary syndrome.
Topics: Acute Coronary Syndrome; Coronary Angiography; Deoxyglucose; Humans; Percutaneous Coronary Intervention; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors | 2023 |
1,5-Anhydroglucitol as a Marker of Acute Hyperglycemia in Cardiovascular Events.
Topics: Acute Coronary Syndrome; Biomarkers; Blood Glucose; Coronary Artery Disease; Deoxyglucose; Glycated Hemoglobin; Humans; Hyperglycemia | 2022 |
Circulating 1,5-Anhydroglucitol as a Biomarker of ß-cell Mass Independent of a Diabetes Phenotype in Human Subjects.
Topics: Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Phenotype; Prediabetic State; Research Subjects | 2022 |
Nonlinear association of 1,5-anhydroglucitol with the prevalence and severity of coronary artery disease in chinese patients undergoing coronary angiography.
Topics: Biomarkers; Blood Glucose; China; Coronary Angiography; Coronary Artery Disease; Deoxyglucose; Glycated Hemoglobin; Humans; Prevalence; Risk Factors | 2022 |